India is mainstreaming traditional Indian medicine within its public health system, with the government working to operationalize 12,500 Ayush Health and Wellness Centres and supporting 17 Integrated AYUSH hospitals in southern states.

The Ministry of Ayush is also pushing insurance coverage for AYUSH care by developing Standard Treatment Guidelines and empanelling AYUSH hospitals, aiming to improve accessibility and affordability.

The World Health Organization is investing $250 million in India to build a Global Centre for Traditional Medicine to generate an evidence base and help countries integrate traditional practices.

This WHO Global Centre for Traditional Medicine is being established in Jamnagar, Gujarat, to leverage traditional Indian practices for global good.

Key institutions advancing research and clinical services include the All India Institute of Ayurveda in Goa, the National Institute of Unani Medicine in Ghaziabad, and the National Institute of Homoeopathy in Delhi.

The Central Council for Research in Ayurvedic Sciences (CCRAS) leads government-backed research in Ayurveda, including clinical tools such as AYUSH QOL2C for improving quality of life in cancer patients.

Additional centres include the Central Research Institute of Yoga & Naturopathy in Dibrugarh with a 100-bed hospital and an incubation centre for wellness startups.

Regional hubs such as the Ayurvedic Medical College & Hospital at Akhnoor and the Unani Medical College & Hospital at Ganderbal further expand the Indian System of Medicine infrastructure.

A frequently cited example of clinical application is an IIT Delhi study showing that personalized Ayurveda medicines and therapeutic Yoga benefited high-risk COVID-19 patients, with 90% of symptomatic patients improving within nine days and none progressing to severe endpoints.

Parallel research highlights neem (Azadirachta indica) as a promising antiviral; neem bark extract has been shown to target coronavirus viral proteins and exhibits anti-parasitic and anti-bacterial properties, with prior evidence in malaria and skin diseases.

Indian researchers have also explored Himalayan plant petals for antiviral activity against COVID-19, signaling a broader pipeline of botanicals under investigation.

Ashwagandha (Withania somnifera) is under a large clinical trial for Long COVID in the UK, where 2,000 participants take 500 mg twice daily for over a year, a program funded by the Ministry of Ayush and supported by WHO.

Green chiretta (Andrographis paniculata), used in South Asian herbal traditions, has been reported to achieve a 99.02% recovery rate in coronavirus cases and was approved by Thailand as an effective herbal treatment, although more studies are needed to verify efficacy and side effects.

Diabetes is a major application area, with studies indicating Ayurveda can help maintain blood sugar in type 2 diabetes with fewer side effects compared to some modern drugs, including the use of turmeric in care plans.

BGR-34 is an Ayurvedic formulation containing compounds from four medicinal herbs that has been reported to reduce blood sugar levels and address obesity, reflecting efforts to standardize multi-herb anti-diabetic formulations.

Mechanistic research supports turmeric’s curcumin in improving insulin sensitivity and metabolic function, underpinning its anti-hyperglycemic role in diabetes management.

Because native curcumin has low bioavailability, nano-formulations and the adjuvant piperine are being developed and studied to significantly enhance its oral bioavailability and therapeutic potential.

Integrative oncology is emerging, with Ayurveda used as complementary care, while tools like AYUSH QOL2C have shown improved quality of life in cancer patients receiving conventional cancer treatment.

Beyond oncology, essential oils used in traditional Indian medicine demonstrate antioxidant, antimicrobial, and anticarcinogenic properties, suggesting broader preventive and adjunctive roles.

Mental health and rehabilitation are active fronts for Indian herbal medicine, with Ashwagandha repeatedly shown to reduce anxiety and stress, partially via GABAergic pathways and anti-inflammatory effects, and to improve muscle strength and reduce fatigue.

A large randomized program is testing Ashwagandha for Long COVID–related fatigue and anxiety, reflecting growing interest in mind–body–herbal integrative strategies.

Other reported applications include ophthalmology claims from Dr Basu Eye Hospital, where herbal eye drops were reported to improve vision in cataract and glaucoma patients, though these findings are based on institutional reports and warrant independent verification.

Traditional therapies are also used for musculoskeletal and sensory disorders, and some centres combine Ayurveda with osteopathic and chiropractic techniques in integrative practice.

Digital health and hybrid care models are accelerating access to integrative therapies, exemplified by RaphaCure’s partnership with Madhavbaug to deliver preventive cardiac care using Ayurvedic protocols through telemedicine and remote patient monitoring.

The telemedicine push reflects India’s broader trend of leveraging technology to extend non-invasive, integrative care into remote regions.

On the research side, India’s National Medicinal Plant Board maintains data on hundreds of medicinal plants, strengthening the resource base for drug discovery and standardization efforts.

Quality, safety, and regulation are central to scaling Indian herbal medicine responsibly, and India has created a regulatory pathway for plant-based drugs called phytopharmaceuticals to bridge traditional knowledge and modern drug standards.

The Ministry of Ayush has warned manufacturers against misleading claims, while the National Pharmacovigilance Centre monitors safety under the Drugs and Cosmetics Act.

India is revising Schedule M to align Good Manufacturing Practices with WHO standards and has mandated GMP adoption across the industry, steps designed to strengthen quality control.

The government has also issued new standards requiring companies to test ingredients before marketing finished products, and recent inspections highlighted quality gaps that must be addressed within tight timelines.

Regulators report instances of substandard products and are augmenting oversight, including risk-based inspections and market withdrawals when quality parameters fail.

India has allocated $80 million to strengthen the drug regulatory system after quality lapses, including global incidents that underscored the need for robust manufacturing and surveillance.

India is also pursuing international standardization by seeking Ayurveda’s inclusion in WHO’s ICD-11 and enhancing adverse event reporting through the National Ayush Morbidity portal.

Safety considerations for herbal therapies remain important for clinicians and patients.

Some Ayurvedic products have been found to contain heavy metals, and rare cases of lead poisoning have been documented, highlighting the need for sourcing from reputable, quality-checked suppliers.

Herbal products can interact with conventional medicines—examples include interactions with blood thinners—and adverse effects such as gastrointestinal or cardiovascular symptoms have been reported with some supplements.

Regulators and public health agencies have also flagged instances of adulteration with banned substances in herbal products, underscoring the need for stricter oversight and consumer vigilance.

The global herbal medicine market was USD 201.06 billion in 2022 and is projected to reach USD 371.45 billion by 2030 at an 8.02% CAGR, with India home to several leading companies and a growing role in pharmaceutical and nutraceutical segments.

This market momentum reflects rising consumer demand for natural, holistic options and is being met by India’s integrative policy push, research investments, and institution-building across Ayurveda and related systems.

Overall, the current evidence suggests Indian herbal medicine can be a useful adjunct to conventional care for specific conditions such as diabetes, anxiety, and supportive cancer care, while larger, well-controlled clinical trials and strong regulation remain essential to fully establish efficacy and safety.

India is mainstreaming traditional Indian medicine within its public health system, with the government working to operationalize 12,500 Ayush Health and Wellness Centres and supporting 17 Integrated AYUSH hospitals in southern states.

Title:

Content: you are here: HomeNewsIndia

Govt working towards scientifically integrating traditional and modern medicine: Sonowal

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

September 07, 2023 / 12:48 AM IST

Ayurveda representational image

India's rich heritage of traditional form of medicine has withstood the test of time and the government has been working towards scientifically integrating it with modern medicine, Union Ayush Minister Sarbananda Sonowal said on Wednesday.

The Regional Review meeting of National Ayush Mission was ceremonially inaugurated by him along with his deputy Munjpara Mahendrabhai.

During the meeting, representatives of all participating states and Union territories presented detailed presentations on the state of Ayush and progress of leading Ayush programmes under implementation.

Speaking on the occasion, Sonowal said, "Our rich heritage and potential of traditional form of medicine has withstood the test of time in generations of humanity to live a better, healthier and happier life. We must take full advantage of this generous forms of medicine - be it Ayurveda, Siddha, Unani, Yoga, Naturopathy, Sowa Rigpa, or Homoeopathy."

He also said that under the visionary leadership of Prime Minister Narendra Modi, the government has been working towards scientifically integrating traditional forms of medicine with the modern medicine.

Highlighting the utility of Ayush system of medicine, he further said that it has some robust programmes like Ayurvidya for promotion of healthy lifestyle through Ayush for school children, Supraja for maternal and neonatal intervention, Vayomitra for geriatric issues; prevention and management of Osteoarthritis and other musculo-skeletal disorders, and Ayush mobile medical units.

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

The ministry of Ayush has so far released Rs 719.70 crore to southern states and Union territories - Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu and Telangana - under NAM since 2014-15, he said, adding it has also supported 17 Integrated Ayush hospitals in the southern states and out of that six are operational as reported by them.

Mahendrabhai stressed on the need to emphasise on outcomes as a more meaningful measure of programme value than output.

"We may have to realign our strategies and techniques to plan, execute and report our performance that facilitates measure of outcomes," the minister of state for Ayush said.

NAM is being implemented with the vision and objectives to provide Ayush health care services throughout the country by strengthening and improving facilities, to provide informed choice to the needy public.

PTI
first published: Sep 7, 2023 12:47 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

What is the traditional Indian medical system called?

The Ministry of Ayush is also pushing insurance coverage for AYUSH care by developing Standard Treatment Guidelines and empanelling AYUSH hospitals, aiming to improve accessibility and affordability.

Title:

Content: Sensitisation programme of general insurance companies in Delhi on May 27

The programme will take place on May 27, at All India Institute of Ayurveda in the national capital.

To foster a deeper understanding and collaboration between the insurance sector and provide affordable Ayush healthcare to all citizens, Ayush Hospitals & healthcare providers, the Ministry of Ayush, government of India is organising a sensitisation programme specially designed for Executive leadership teams of General Insurance Companies and owners of Ayush Hospitals.

The programme will take place on May 27, at All India Institute of Ayurveda in the national capital. It intends not just to enhance the accessibility and affordability of Ayush treatments for the public, ultimately promoting holistic health and wellness across the nation, but also facilitate in the empanelment of public and private Ayush hospitals for insurance coverage in India.

The programme will discuss the regulatory framework and policy support needed to mainstream Ayush treatments in health insurance schemes and facilitate a dialogue between key stakeholders to address both challenges and opportunities.

Advertisement

Other key issues of discussion are Insurance coverage in Ayush Sector, Standard Treatment Guidelines (STG) & ICD Codes for Insurance Sector, Penetration of Ayush in Insurance Sector, Ayush Hospital’s Prospective, Achievements and Success Stories of AIIA, On boarding of Ayush hospitals on ROHINI platform, Empanelment of Ayush hospital for insurance coverage.

Vaidya Rajesh Kotecha, Secretary, Ministry of Ayush, Prof. Bejon Kumar Misra, Chairman, Core Group of Experts for Insurance, Ministry of Ayush, Dr. Kousthubha Upadhyaya, Adviser, Ministry of Ayush, Dr. A. Raghu, DDG, DGHS, Mr. Rajeev Vasudevan, AyurVaid Hospital, Prof. Anandaraman P. V., Shri Mukund Kulkarni Head Health, Dr. Alka Kapoor, DMS, AIIA, Sh. YoganandaTadepalli, CTO, IIBI &Mr Segar Sampathkumar, GIC will be the key speakers.

Advertisement

The World Health Organization is investing $250 million in India to build a Global Centre for Traditional Medicine to generate an evidence base and help countries integrate traditional practices.

Title:

Content: Archive / Lifestyle
The World Health Organization is interested in alternative medicine.
Mohamed Ismail - Cairo - DPA -
Many people use traditional medicine – but what do these methods really do?
A new WHO centre intends to explore this.
The center is based in India, a country where alternative medicine is so important that it even has its own ministry – which specializes in Ayurveda, Yoga, Physiotherapy, Greek Medicine, Master and Homeopathy.
Indian Prime Minister Narendra Modi attended the opening of the centre in Jamnagar in mid-April, saying: “India ’ s traditional medicine system is not just a cure.
It ’ s a comprehensive science of life. ”
According to the World Health Organization (WHO), the Indian government is supporting the centre with US $250 million (230 million euros).
WHO President Tedros Adhanom Ghebreyesus said: “The center aims to be an engine of innovation, moving towards an agenda of evidence, data and sustainability in traditional medicine, ” adding that the center would connect traditional medicine practitioners around the world and help set standards for research.
Traditional medicine is a broad field.
According to the World Health Organization ’ s statement for the center, 80% of the world ’ s population uses traditional medicine, which includes among other things acupuncture, Ayurvedic medicine and herbal blends.
Traditional medicine is also represented in modern science.
According to the World Health Organization, about 40% of all drugs approved today are derived from natural substances.
The discovery of aspirin, for example, is based on ancient recipes made from the bark of the willow tree.
The research for artemisinin for use in the fight against malaria, for which the Nobel Prize was awarded in 2015, began with the study of ancient texts of Chinese medicine.
George Rochmeyer of Cochrane, an international network that provides the scientific basis for decisions in the health field, said it makes sense at least to take a closer look at treatment methods that have been developed over centuries, to verify the reasonableness of these methods, and to conduct clinical studies on them in case of doubt.
Cochrane reviews are systematic reviews that collect all scientific evidence on a specific issue from medicine or other health sciences.
However, Rochmeyer also stressed that besides the examples of traditional methods cited by the WHO, which form the basis of currently developed treatments, there are likely many other examples where traditional methods of careful review have proven ineffective or even dangerous, such as phlebotomy, noting that spending too much money on studies to review a therapeutic practice is always a matter of discretion.
Rochmeyer stated that there are many Cochrane reviews about the use of traditional methods such as acupuncture in certain cases, but: “From my personal experience at Cochrane, I would say that I have not come across many reviews that have shown really compelling evidence for traditional therapeutic practice. ”
This is often due to the fact that when searching for these treatments we find only a few often-poorly conducted studies that cannot prove or disprove any benefit from them – which brings us back to the question of whether the already limited research funds should be invested in a scientifically unreasonable procedure – for example, homeopathy.
Professor Emeritus Edzard Ernst, a longtime professor of alternative medicine at the University of Exeter, noted that while it was necessary to wait and see who would lead the center and what it would do, the WHO press release was full of exaggerations.
The World Health Organization says it also wants to use new technologies at the new center for the study of traditional medicine — via artificial intelligence and big data, for example.
The center is expected to focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.
In addition, the center is supposed to help countries integrate these practices into their health systems.
You may also read.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

This WHO Global Centre for Traditional Medicine is being established in Jamnagar, Gujarat, to leverage traditional Indian practices for global good.

Title:

Content: For Quick Alerts
ALLOW NOTIFICATIONS
For Daily Alerts

Yoga Uniting World In Pursuit Of Good Health, Wellness, Says Prime Minister Modi

By

Prime Minister Narendra Modi on Saturday said yoga is uniting the world in pursuit of good health and wellness as he lauded the Indian embassy's "great effort" in Doha for holding a yoga session for people of 114 nationalities. In his tweets, Modi also referred to the Ministry of Ayush signing the 'host country agreement' with the World Health Organization for establishing the WHO Global Centre for Traditional Medicine in Jamnagar, Gujarat, and said India is honoured to be home to such a state-of-the-art centre.

"This centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good," he said.

Traditional medicines and wellness practices from India are very popular globally, he noted, adding that the WHO centre will go a long way in enhancing wellness in society.

The World Health Organization had earlier tweeted that it and the Indian government have agreed to establish the WHO Global Centre for Traditional Medicine to maximise the potential of traditional medicines through modern science and technology.

Story first published: Monday, March 28, 2022, 10:30 [IST]
Read more about: yoga wellness

Key institutions advancing research and clinical services include the All India Institute of Ayurveda in Goa, the National Institute of Unani Medicine in Ghaziabad, and the National Institute of Homoeopathy in Delhi.

Title:

Content: Three National Ayush institutes inaugurated by Prime Minister Narendra Modi

New Delhi : The nation today got three National Ayush Institutes of eminence in Ayurveda, Homoeopathy and Unani. Prime Minister Shri Narendra Modi today virtually inaugurated All India Institute of Ayurveda in Goa, National Institute of Unani Medicine in Ghaziabad, and National Institute of Homoeopathy at Delhi from Goa.

The Prime Minister was participating in the valedictory ceremony of the 9th World Ayurveda Congress (WAC) at Panjim, Goa. The four days deliberation at 9th WAC provided a global platform for national and global stakeholders, industry leaders, practitioners, traditional healers, educationists, and manufacturers for engaging in intellectual exchange to strengthen the Ayurveda sector.

The valedictory ceremony was attended by Shri P. S Sreedharan Pillai, Governor of Goa, Shri Pramod Sawant, Chief Minister, Goa, Shri Sarbananda Sonowal, Union Cabinet Minister of Ayush and Ports, Shipping & Waterways and Dr. Munjpara Mahendrabhai, Minister of State for Ayush and Women & Child Development. Shripad Yesso Naik, Minister of State for Tourism and Ports, Shipping and Waterways and President, Vijnana Bharati and others were also present.

Addressing the gathering Prime Minister Shri Narendra Modi, said, “We need to continuously work toward the documentation of ‘Data Based Evidence’, we had Ayurveda’s results as well as effects in our favour, but we were lagging behind in terms of evidence. He emphasized that our medical data, research, and journals have to be brought together to verify every claim on modern scientific parameters.”

He added that more than 30 countries have recognized Ayurveda as a traditional medicine system and we have to further promote Ayurveda in every country of the world. PM emphasized that Ayurveda is not just about treatment, it also promotes wellness. The world is now returning to our traditional medicine and Yoga and Ayurveda are the new hope for the world.

On this occasion, Shri Sarbananda Sonowal said, “Ayush Ministry is committed to imparting Ayush health systems into day to day life of the common man by strengthening systems in Health as well as the Education sectors to the people of India. We want Ayush system to become a part of every household not only in India but globally and are trying our best to fulfill dream of Heal in India.”

The Ayush Minister further added, “with the rapid strides in the Ayush sector, in India’s Azadi ka Amrit Kaal, I firmly believe that under the guidance of PM Shri Narendra Modi, it will certainly be ‘Ayush Ka Amrit Kaal’.

Shri Vijay Kumar Saxena, Lt. Governor, Govt of NCT was the chief guest at National Institute of Homoeopathy (NIH), Delhi. It is a first of its kind to be established in Northern India for developing the Homoeopathic system of medicine. General (Retd) V.K. Singh, Union MoS for Road Transport & Highways and Civil aviation was chief guest at National institute of Unani Medicine (NIUM), Ghaziabad.

Prime Minister also visited Arogya Expo held along with 9th WAC and keenly observed and interacted with participants of the Expo.  Various Ayush institutes and research councils, more than 215 companies, leading Ayurveda’s brands, medicine manufacturers and Ayurveda related educational and R&D institutions participated in the Arogya Expo.

The Central Council for Research in Ayurvedic Sciences (CCRAS) leads government-backed research in Ayurveda, including clinical tools such as AYUSH QOL2C for improving quality of life in cancer patients.

Title:

Content: India Cancer Treatment Drugs Market Huge Gains Projected for Market Over Next 7-Year Period

Quadintel offers a thorough analysis of the global “ India Cancer Treatment Drugs Market “, including assessments of business solutions, studies and advancements, applications, advantages, benefits, and breadth.

This market research study provides a thorough analysis and improvement of the important business producers, opportunities, difficulties, and worldwide suppliers as well as a close investigation of risks and access restrictions. Additionally, it provides a competitive analysis of the most recent technological advancements, innovations, future market potential, industry share, sales, sales generation, funding analysis, and overall business environment.

Download Free Sample of This Strategic Report :-https://www.quadintel.com/request-sample/india-cancer-treatment-drugs-market/16-13-1050

Insights into the Market During the Forecast Period (from 2023 to 28), the India Cancer Treatment Drugs Market is anticipated to expand at a CAGR of approximately 12.2%. In India, the disease has emerged as a concern for public health, with an estimated 1.39 million cases expected in 2020. In the past, more than 0.8 million people died from cancer in India in 2019.

The National Institute of Cancer Prevention and Research estimates that one woman in India dies from cervical cancer every eight minutes. In India, one woman dies from breast cancer for every two newly diagnosed women. In addition, the country’s tobacco use is on the rise, resulting in an increase in tobacco-related cancer deaths.

Changes in eating habits, food adulteration, environmental changes, an increase in chemical factories, etc., all contribute to a steady rise in cancer cases. are the main considerations for heightening malignant growth cases in India. Aside from these, an increase in cancer patients has been caused by a sedentary lifestyle and an excessive intake of junk food over the past few years. Accordingly, the requirement for convenient determination and preventive consideration is flooding at an outstanding speed, prompting broad interests in Research and development, in this manner making way for medication producers to concoct more viable medications to address such acceleration in the country.

Since the developed markets are relatively saturated in this industry, India has also seen remarkable opportunities for venture capitalists and investors. Additionally, the Ayushman Bharat Scheme’s effective diagnosis and treatment of cancer as well as the All India Institute of Medical Sciences (AIIMS)’s growing focus on oncology are likely to boost drug sales for cancer treatment. In addition, the industry has been positively impacted by the ever-increasing demand for effective medicines and the ever-improving infrastructure for cancer care in recent years, which includes upgraded facilities for tertiary care.

Mostly in the states of Madhya Pradesh, Odisha, Assam, Uttarakhand, Himachal Pradesh, Haryana, Delhi, Maharashtra, and Karnataka, among others, where the incidence of lip, oral, breast, and cervical cancer accounts for the majority of the cases. Consequently, requiring these cancer-related medications and accelerating their production during the anticipated time frame.

Request full Report Description, TOC, Table of Figure, Chart, etc : –https://www.quadintel.com/request-sample/india-cancer-treatment-drugs-market/16-13-1050

Key driver:

Market Dynamics Numerous Programs Promoting Affordable and Effective Cancer Diagnosis and Treatment One of the main focuses of the Pradhan Mantri Jan Arogya Yojana is protecting beneficiaries from the devastating costs of cancer treatment. Screening for oral, breast, and cervical cancer, as well as other common non-communicable diseases, is one of the services provided by the Ayushman Bharat Health and Wellness Centers (AB-HWCs).

Similar to this, the Ministry of Chemicals and Fertilizers’ National Pharmaceutical Pricing Authority (NPPA) published a list of 390 non-scheduled anti-cancer medications in 2019 with MRP reductions of up to 87 percent. This activity helped 22 lakh malignant growth patients in the country and would save buyers about Rs. 800 crores per year. Indian pharmaceutical companies are currently on an acquisition binge after a decade of prudent and organic growth. Additionally, cancer medications appear to be their primary focus, which ultimately drives the pharmaceutical industry.

Possible Limitation:

Access to medications like trastuzumab, rituximab, and bortezomib has been restricted as a result of rising catastrophic spending, which is characterized by significant OPP (out-of-pocket) expenditure in the private health care system. This is because the private sector has demonstrated significantly higher expenditure levels.

The study, which was supported by the Global Challenges program of the University of Birmingham, the India Institute of the University of Birmingham, and the National Institute for Health Research (NIHR), found that, depending on the type of cancer, patients were required to pay out-of-pocket expenses ranging from 19,494 to 295,679 Indian Rupees (INR).

The burden for health products and services decreases as a result of OPP payments, which include cost-sharing, self-medication, and other direct patient-borne costs that are not fully covered by insurance. This may have a negative impact on the industry in the coming years.

Learning experience: Ayurveda-Based Malignant growth Drug and Treatments

The public authority has put forth various attempts to energize Ayurveda research and the advancement of disease treatments. The government-established independent Central Council for Research in Ayurvedic Sciences (CCRAS) has conducted research on cancer, worked on drug development, and documented medical procedures, including the creation of AYUSH QOL2C to improve the quality of life for people with the disease. As a result, pharmaceuticals based on Ayurveda are likely to offer competitive businesses lucrative opportunities in the coming years.

Download free sample of this report :-https://www.quadintel.com/request-sample/india-cancer-treatment-drugs-market/16-13-1050

Key Pattern:

Increasing the number of cancer tertiary care facilities in the country The Central Government is expanding the Tertiary Care of Cancer Scheme to increase the number of resources for tertiary cancer care. So far, the program has approved 19 State Cancer Institutes (SCIs) and 20 Tertiary Care Cancer Centers (TCCCs). Six institutions have been established in Sikkim, Uttar Pradesh, Gujarat, Bihar, Tamil Nadu, and Kerala up until this point. The 33 other institutes are developing in various stages. Therapies and medications are necessary for better care, so developing tertiary care is likely to shape the industry in the coming years.

Market Division

In light of Treatment Type,

Chemotherapy
Designated Treatment
Immunotherapy
Hormonal Treatment
Other Treatment Types

The Designated treatment portion achieved the biggest market development in the authentic period. It is primarily attributable to the advanced efficacy, higher survival rates, and enormous potential of targeted therapies to kill only malignant cells. Then again, the immunotherapy portion is supposed to enlist the quickest development during 2023-28.

This monstrous development is related with the escalation of the frequencies of disease in India and the absence of related clinical help with the country. In addition, India’s public reimbursement programs do not include costly cancer medicines because it is one of the health systems with the fewest resources. This could result in catastrophic expenditure risks. Systemic anticancer therapy must therefore be thoroughly evaluated before being included in national formularies.

Request full Report Description, TOC, Table of Figure, Chart, etc : –https://www.quadintel.com/request-sample/india-cancer-treatment-drugs-market/16-13-1050

Cytotoxic drugs, targeted drugs, hormonal drugs, and others made up the majority of the medicines with the highest priority. Deeply grounded cytotoxic medications, presented to worldwide conventional contest in the beyond 10-20 years, incorporate doxorubicin, cyclophosphamide, paclitaxel, carboplatin, methotrexate, cytarabine, capecitabine, fluorouracil, and gemcitabine.

Moreover, Nonexclusive Chemotherapy specialists are the most high-need malignant growth medications by Indian oncologists as they work with significant enhancements in endurance and are now remembered for WHO EML. Recent Developments in the India Cancer Treatment Drugs Market In August 2022, AstraZeneca India, a pharmaceutical company, announced that the Drugs Controller General of India had given the go-ahead to commercialize its medication for breast cancer treatment, Lynparza (Olaparib), as a monotherapy.

PHESGO was the first ever fixed-dose formulation in oncology to combine two monoclonal antibodies – Perjeta (pertuzumab) and Herceptin ( Lynparza is the solitary endorsed medication focusing on BRCA (Bosom Disease quality) changes in beginning phase bosom malignant growth.

Dostarlimab, a medicine made in a lab that acts as a surrogate for antibodies in the human body, was discovered to have the potential to be a “possible” cancer cure for one of the most deadly tumors in a small clinical trial conducted by Memorial Sloan Kettering Cancer Center in June 2022 for the first time in history.

Are you in need of additional assistance?

The purpose of the sample report is to familiarize you with the overall research content and layout.
If you use the report strategically, you might be able to make your operations even more efficient and make more money.
You can customize the report to fit your needs by adding additional segments and specific countries. This will give you an unrivaled competitive advantage in your sector.
Feel free to get in touch with one of our knowledgeable analysts if you want more information about the current market situation.

Highlight the Following Key Factors:

  • Business Description: a particular description of agency operations and enterprise departments.
  • Company Strategy: The analyst’s precis of the company’s commercial enterprise strategy.
  • SWOT Analysis: Detailed evaluation of the company’s strengths, weaknesses, opportunities, and threats.
  • Company History: The development of predominant occasions associated to the company.
  • Main merchandise and services: A listing of the company’s fundamental products, services, and brands.
  • Main Competitors: A listing of the company’s fundamental competitors.
  • Important places and subsidiaries: The company’s major places and subsidiaries’ listing and contact information.
  • Detailed economic ratios of the previous 5 years: The trendy monetary ratios come from the annual economic statements issued by means of agencies with a record of 5 years.

Request Full Report :-https://www.quadintel.com/request-sample/india-cancer-treatment-drugs-market/16-13-1050

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Quadintel is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

  • Robust, detailed segmentation
  • In-depth analysis in all geographies.
  • Detailed breakup in various segmentation.
  • Rigorous primary and secondary research

We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization. Our priority is to provide high-level customer satisfaction by providing innovative reports that enable them to take a strategic decision and generate revenue. We update our database on a day-to-day basis to provide the latest reports. We assist our clients in understanding the emerging trends so that they can invest smartly and can make optimum utilization of resources available.

Get in Touch with Us:

Quadintel:
Email:sales@quadintel.com
Address: Office – 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website : https://www.quadintel.com/

Additional centres include the Central Research Institute of Yoga & Naturopathy in Dibrugarh with a 100-bed hospital and an incubation centre for wellness startups.

Title:

Content: Dibrugarh (Assam) [India], January 28 (ANI): Union Minister of Ports, Shipping & Waterways and Ayush, Shri Sarbananda Sonowal along with Assam Chief Minister Dr Himanta Biswa Sarma on Sunday laid the foundation stone of the Central Research Institute of Yoga & Naturopathy (CRIYN) along with a 100 bedded Yoga and Naturopathy hospital at Dihing Khamtighat in Dibrugarh.

The institution will be developed over a land parcel of nearly 15 acres (45 bighas) at an approximate investment of Rs 100 crore, with an aim at bringing a scientifically valid and useful synergy between traditional knowledge of Yoga and Naturopathy and modern tools of technology.

Also Read | Lok Sabha Speaker Om Birla Says Committee To Be Formed Under Maharashtra Assembly Speaker Rahul Narwekar To Review Country's Anti-Defection Law.

It will establish benchmark standards in education, Preventive healthcare and research in the field of Yoga and Naturopathy. This state-of-the-art institute will focus on fundamental aspects, scientific validation of traditional systems of medicine and practices through evidence based research, apart from functioning as an international collaboration centre for global promotion and research in Yoga and Naturopathy.

The institute will also serve as incubation centres in startups in the field of Yoga and wellness sector.

Also Read | Thane Shocker: Three-and-Half-Year-Old Missing Boy Found Dead in Residential Building's Water Tank in Bhiwandi, Probe Underway.

Speaking on the occasion, the Union Minister of Ports, Shipping & Waterways and Ayush, Sarbananda Sonowal, said, "Under the visionary leadership of Prime Minister Narendra Modi ji, the Ayush movement has got a tremendous boost as it has become a pioneering force of global wellness movement. Modiji's unrelenting focus to power India's growth engine with Northeast as powerhouse is resulting unprecedented growth. Today, we lay the foundation stone for the first of its kind Central Research Institute of Yoga & Naturopathy with a 100 bedded hospital in Dibrugarh. This is yet another testament of Modiji to empower Assam and the whole of Northeast to harness its rich flora & fauna and drive expansion in Ayush sector, with peripheral growth in hospitality, patient care as well as medical tourism sectors as well. Mother Nature has blessed us with her immense beauty and this will go a long way in providing a healing touch for people, of not just the immediate region but the South Asia region, with the rejuvenated, scientifically validated treatment regime through Yoga, Naturopathy, Ayurveda and other traditional forms of medicine."

"The institution will also offer clinical training facilities to train Yoga and Naturopathy experts for capacity building programs in areas of cardiac rehabilitation, Diabetes Rehabilitation, autoimmune diseases and NCD risk reduction," he added.

Sarbananda Sonowal also said that, with research and development in the protocols of Yoga and Naturopathy, CRIYN will develop evidence based protocols for management of NCDs that can be integrated with conventional care, reinforcing the Integrated Medicine approach of patient care.

The hospital will provide for inpatient services with Yoga and naturopathy protocols to heal and enrich quality of lives.

On this occassion Sarbananda Sonowal talked about Atmanirbhar Bharat stating, Modiji makes it a point to empower, enable and energise Northeast as the Powerhouse of India's economic growth, we stand at the threshold of an opportunity to seize the moment as India cruise towards becoming an Atmanirbhar Bharat.

Adding further, Sarbananda Sonowal said, "Dibrugarh has an illustrious history as the nerve centre of this region. Endowed with natural resources, it has always proved as a major driver of growth. Under the inspiring leadership of Prime Minister Narendra Modi ji, this growth saga has gained momentum since 2014. The resurgence of Ayush at the forefront of global wellness movement not only provides an economic rationale for India, but, more importantly, it is the virtuous and apt direction towards building a Swastha Bharat - a vision of Modiji. Today's initiative is a strong step towards realisation of this beautiful vision."

The event was also graced by the Union Minister of State Rameswar Teli, the Minister of Health & Family Welfare of Assam, Keshab Mahanta, the Minister of Industries & Commerce and Culture, Bimal Borah; the MLA of Dibrugarh and Chairman, Assam Industrial Development Council (AIDC), Prasanta Phukan; MLA of Moran, Chakradhar Gogoi, MLA of Duliajan, Terash Gowalla; MLA of Lahowal, Binod Hazarika; MLA of Chabua, Ponakan Baruah; MLA of Naharkatia, Taranga Gogoi among other dignitaries including senior officials of the Ministry of Ayush as well as Government of Assam.

"The centre will provide inpatient, outpatient, and day care services. The services offered by the centre are naturopathy diet and nutrition, yoga therapy, massage & manipulative therapies, acupressure, acupuncture, chromotherapy, magneto therapy, physiotherapy and hydrotherapy treatments," Sarbananda Sonowal said.

"It will help patients to effectively manage Obesity, Metabolic syndrome, diabetes, CVD, stroke, Asthma, COPD, Migraine, IBS, IBD, Arthritis, Autoimmune diseases, cancer, neurodegenerative diseases," he added.(ANI)

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)

Regional hubs such as the Ayurvedic Medical College & Hospital at Akhnoor and the Unani Medical College & Hospital at Ganderbal further expand the Indian System of Medicine infrastructure.

Title:

Content: J&K Has Been A Major Center Of Indian System Of Medicine Since Ancient Times: LG Sinha

– Lt Governor addresses Consultative meeting of Commission for Indian System of Medicine.
– Reiterates J&K Government's commitment to make the UT a hub of medical and wellness and to contribute to PM Narendra Modi's vision of ‘Heal in India' and ‘Heal by India'.
– With a rich legacy of medicine system, we are committed for investment and innovation in AYUSH and to strengthen traditional system of medicines. It has tremendous growth potential and J&K bestowed with nature's bounty and rich medicinal plants will promote startups and business units in AYUSH: LG.
– LG highlights several milestones achieved in AYUSH sector of J&K UT.
– Ayurvedic Medical College & Hospital at Akhnoor, Unani Medical College & Hospital at Ganderbal and upgradation of 442 AYUSH Dispensaries have been done for well-being of the people: LG.
– Five 50-Bedded Integrated AYUSH Hospitals in Districts of Kulgam, Kathua, Kupwara, Kishtwar and Samba have been approved by Ministry of AYUSH under National AYUSH Mission to strengthen AYUSH secondary healthcare in the UT of J&K: LG.
– In order to promote Medical Tourism in UT, 6 Specialized AYUSH Wellness Centres at famous tourist places-Pahalgam, Gulmarg, Sonamarg, Patnitop, Katra and Golf Course & Srinagar have been approved, out of which three centres have been made operational: LG Sinha.

Srinagar, Jun 2: Lieutenant Governor Manoj Sinha addressed a Consultative meeting on “Ayushman Bharat Digital Mission – Heal in India, Heal by India,” organized by National Commission for Indian System of Medicine (ISM), Ministry of AYUSH, today at University of Kashmir. Addressing the gathering of health professionals and practitioners of ISM from across the country, the Lt Governor reiterated the commitment of the J&K Government to making the UT a hub of medical and wellness tourism and to contribute to Prime Minister Narendra Modi's vision of ‘Heal in India' and ‘Heal by India'.
He said the deliberations during this important meeting will build a solid framework for exchange of ideas to promote ISM and implementation of two important components of Ayushman Bharat Digital Mission – Healthcare Professional Registry and Healthcare Facility Registry in the UT.
“J&K has been a major center of the Indian system of medicine since ancient times and according to Kalhana's Rajtarangini, a well developed Ayurveda hospital was functional those days. Kalhana wrote that J&K had flourishing Ayurvedic drug manufacturing units and Ayurvedic pharmacies,” said the Lt Governor. With such a rich legacy, we are committed for investment and innovation in AYUSH and to strengthen the traditional system of medicines. It has tremendous growth potential and J&K bestowed with nature's bounty and rich medicinal plants will promote startups and business units in AYUSH, he added. He said the world has recognized the Indian System of Medicine as the oldest, effective and scientific health system for prevention and cure. Now the time has come to connect the new generation with this heritage and rich legacy to fulfil the vision of One Earth, One Health, he added. At the consultative meet, the Lt Governor shared the efforts to strengthen the basic health infrastructure, promote medical tourism in the J&K UT and provide the people with access to world class, affordable and quality healthcare services.
Under the guidance of Prime Minister Narendra Modi ji, the Ministry of AYUSH and J&K administration are working together with the vision of ‘One Earth, One Health' to serve the global community through integrated and ancient Indian System of medicine, he said.
Jammu Kashmir is fully prepared to become an important centre of AYUSH and ‘Heal in India' campaign, which will not only promote medical tourism in the Union Territory, but also create immense business and employment opportunities in the healthcare sector, added the Lt Governor. The Lt Governor also highlighted several milestones achieved in the AYUSH sector of J&K UT. Ayurvedic Medical College and Hospital at Akhnoor, Unani Medical College and Hospital at Ganderbal and upgradation of 442 AYUSH Dispensaries have been done for the well-being of the people. Five 50-Bedded Integrated AYUSH Hospitals in Districts of Kulgam, Kathua, Kupwara, Kishtwar and Samba have been approved by Ministry of AYUSH under National AYUSH Mission to strengthen AYUSH secondary healthcare in the UT of J&K, he said.
In order to promote Medical Tourism in UT, 6 Specialized AYUSH Wellness Centres at famous tourist places-Pahalgam, Gulmarg, Sonamarg, Patnitop, Katra and Golf Course Jammu and Srinagar have been approved, out of which three centres have been made operational, he further added. India is home to the world's oldest medical systems. It is not limited to treatment only. It is a science of understanding life and wellbeing in a holistic manner. Through Yoga and Ayush Centres, it is our endeavour to spread the vision and benefits of Ayurveda to all sections of the society, observed the Lt Governor. The Lt Governor also shared valuable suggestions for integrating local health traditions with the mainstream of Ayurveda by promoting People's Science preserved for centuries and transcribing the rich and diverse Indian medicine knowledge in simple language for the new generation. It is also necessary to understand the roots of the traditional system to establish harmony between the Registry of Professionals and the Registry of Facility and all other disciplines of medicine, he added.
Vaidya Jayant Deopujari, Chairman National Commission for Indian System of Medicine and Prof. (Vaidya) Rakesh Sharma, President, Board of Ethics and Registration, also spoke on the occasion and threw light on the key features of the Ayushman Bharat Digital Mission and the aims and objectives of consultative meeting. Prof. Nilofer Khan, Vice Chancellor, Kashmir University; Bhupinder Kumar, Secretary, Health & Medical Department; Ayushi Sudan, State Mission Director, Ayushman Bharat Digital Mission; senior officials from National Health Authority, ISM and UT Administration; HoDs and scores of health professionals and Ayurvedacharya were present.

A frequently cited example of clinical application is an IIT Delhi study showing that personalized Ayurveda medicines and therapeutic Yoga benefited high-risk COVID-19 patients, with 90% of symptomatic patients improving within nine days and none progressing to severe endpoints.

Title:

Content: Home » News » education-career » Yoga, Ayurveda Could be Effective in Treating High-Risk Covid-19 Cases, Claims IIT-Delhi Research

Yoga, Ayurveda Could be Effective in Treating High-Risk Covid-19 Cases, Claims IIT-Delhi Research

By: Education and Careers Desk

News18.com

Last Updated: September 13, 2022, 16:36 IST

New Delhi, India

The researchers claimed that that high-risk COVID-19 patients undergo severe anxiety, which may further deteriorate their condition (File Photo)

IIT Delhi researchers suggest that in addition to the treatment for COVID-19, Yoga and Ayurveda maybe instrumental in relieving such patients from anxiety and aid in speedy post-treatment recovery

Advertisement

Yoga and Ayurveda maybe effective in the treatment of high-risk cases of COVID-19, suggests a research study by IIT Delhi on successful treatment of 30 high-risk COVID-19 patients. This study was conducted by a team of researchers at IIT Delhi and Dev Sanskriti Vishwavidyalaya, Haridwar.

The researchers claimed that that high-risk COVID-19 patients undergo severe anxiety, which may further deteriorate their condition. They further suggest that in addition to the treatment for COVID-19, Yoga and Ayurveda maybe instrumental in relieving such patients from anxiety and aid in speedy post-treatment recovery.

Also read| IIT Delhi Launches App to Prevent Bengaluru Floods Like Situation, to Predict Waterlogging

The findings of the study have appeared in the Indian Journal of Traditional Knowledge. The research team consists of Dr Sumitra A Bentur, Private practitioner, Greater Noida (West), Uttar Pradesh, Dr Alka Mishra, Dev Sanskriti Vishwavidyalaya, Haridwar, Uttarakhand; Dr Yogish Kumar, Advait Clinic, Delhi, Dr Sonika Thakral, IIT Delhi, Sanjiv, IIT Delhi and Shaheed Sukhdev College of Business Studies, University of Delhi, Prof Rahul Garg, IIT Delhi.

RELATED NEWS

As per the institute, the patients were prescribed Ayurvedic medicines through telemedicine, and administered a personalized therapeutic yoga programme using video conferencing. Almost all the patients were classified as high-risk owing to one or more of co-morbidities such as diabetes mellitus, hypertension, chronic kidney disease, coronary artery disease (which are known to lead to severe outcomes in cases of COVID-19), and/or age above 60, said IIT Delhi.

“The treatment given to the patients was personalized (in accordance with the classical texts) and took account of each patient’s medical history and the symptoms presented, which made it more effective as compared to a fixed standardized treatment plan," said the IIT.

The treatment included ayurvedic medicines, daily yoga-sessions including deep relaxation techniques, pranayama and basic asanas and some lifestyle modifications. Based on the administered treatment, the cases were categorized into YAS (Yoga-Ayurveda based treatment, with possibly allopathic supplements: 4 patients), YASP (Yoga-Ayurveda based treatment, with possibly allopathic supplements and paracetamol: 6 patients), YAM (Yoga-Ayurveda based treatment, and Modern Western Medicine (MWM), that is, allopathy as adjunct: 6 patients), MYA (first tried MWM, later switched to Yoga-Ayurveda: 14 patients). added the institute.

The patients, most of whom presented with many symptoms prior to the yoga and Ayurveda treatment, were followed-up telephonically regularly until recovery. More than half of symptomatic patients started improving within 5 days (90 per cent within 9 days), more than 60 per cent reported at least 90 per cent recovery within 10 days, added IIT Delhi.

Six patients with oxygen saturation (SpO2) below 95 per cent, benefited through Makarasana and Shithilasana; none progressed to composite endpoints (consisting of admission to Intensive Care Unit, invasive ventilation or death). Considering that approximately 19.3 per cent of the patients with these comorbidities progress to composite end points, the p-value was found to be 7.21 x 10−3.

“The study also demonstrates an urgent need to scientifically examine the Traditional Indian Knowledge systems at the top academic institutions. A timely and suitably designed randomized controlled trial evaluating the efficacy of Ayurveda and Yoga based personalized integrative treatment for COVID-19 would have equipped the people with much more credible and dependable information about their use in managing COVID-19" said Prof Rahul Garg, IIT Delhi, who conceptualized the project.

“Most patients reported that the therapy had a profound impact on their recovery process, with many experiencing improvements with respect to their comorbidities too. By the end of the treatment, several patients had decided to adopt Yoga in their lifestyle, and several turned to the Ayurveda doctors in the team for management/treatment of their comorbidities", said Dr Sonika Thakral who coordinated with the patients for routine follow-up.

“On the whole, the belief of the patients in the efficacy of these traditional systems of medicine was extremely enhanced," said Dr Alka Mishra who administered Ayurveda treatment to some patients. “We are observing an increasing trend towards ancient systems of medicine", said Dr Yogesh Kumar who also administered Ayurveda treatment to some patients.

“The said interventions are believed to have collectively accelerated the recovery process by checking anxiety, instilling peace of mind and enhancing the overall well-being of the patients," said Dr Sumitra A Bentur, private practitioner, who designed the Yoga intervention and conducted Yoga sessions for some of the patients.

Read all the Latest Education News and Breaking News here

Follow us on

About the Author

Education and Careers DeskA team of reporters, writers and editors brings you news, analyses and informati...Read More

first published: September 13, 2022, 16:30 IST
last updated: September 13, 2022, 16:36 IST

What is the traditional Indian medical system called?

Parallel research highlights neem (Azadirachta indica) as a promising antiviral; neem bark extract has been shown to target coronavirus viral proteins and exhibits anti-parasitic and anti-bacterial properties, with prior evidence in malaria and skin diseases.

Title:

Content: Neem tree extract may help treat, cut spread of COVID-19: Study

PTI | New Delhi | Updated: 01-03-2022 15:22 IST | Created: 01-03-2022 15:08 IST
  • Country:
  • India

Extract from the bark of the Neem tree may help treat and reduce the spread of SARS-CoV-2, the virus that causes COVID-19, according to a study led by researchers at the Indian Institute of Science Education and Research (IISER) Kolkata.

The Neem tree, indigenous to India, has been used for thousands of years for its anti-parasitic, anti-bacterial and antiviral properties, the researchers said.

The bark extract has helped treat malaria, stomach and intestinal ulcers, skin diseases and many other diseases, they said. The latest study, published recently in the journal Virology, shows that components of Neem bark may target a wide range of viral proteins, suggesting its potential as an antiviral agent against emerging variants of coronaviruses, including SARS-CoV-2.

''The goal of this research is to develop a Neem-based medication that can reduce the risk of serious illness when someone is infected with coronaviruses,'' said study co-author Maria Nagel, a professor at the University of Colorado School of Medicine, US.

''We hope that scientists won't have to continuously develop new therapies every time a new SARS-CoV-2 variant emerges,'' she said.

Just like how people take penicillin for strep throat, the researchers envision taking the Neem-based drug for COVID-19, allowing them to resume their normal lives without fear of hospitalisation and death.

The scientists investigated the impact of the bark extract against coronaviruses in their laboratories.

Researchers at IISER Kolkata tested the extract in animal models and showed that it had antiviral properties against coronavirus.

Using computer modelling, the researchers predicted that Neem bark extract will bind to the SARS-CoV-2 spike protein at various locations, preventing virus entry to host cells.

The spike protein is used by the SARS-CoV-2 virus to enter and infect cells.

Nagel's lab at the University of Colorado tested the Neem bark extract in SARS-CoV-2 human lung cells.

The extract proved as effective as a preventive drug for infection and also decreased virus replication and spread after infection.

''The next step in our research is to identify the specific components in Neem bark extract that are antiviral. Because these components bind to various regions of SARS-CoV-2, we believe that it will be effective on emerging variants with spike mutations,'' said Nagel.

''We will then determine the formulation of dosage for an antiviral drug to treat coronavirus infections,'' she said.

The findings could guide new antiviral therapeutic efforts to combat the ongoing pandemic, while holding out the promise for treating new coronavirus strains, the researchers added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback

Indian researchers have also explored Himalayan plant petals for antiviral activity against COVID-19, signaling a broader pipeline of botanicals under investigation.

Title:

Content: 00: 00
Expo 2020 Dubai Today
Indian study: Himalayan plant promising in treatment of COVID-19 infection
T + T - normal size
In addition to regular vaccinations recommended to combat the novel coronavirus COVID-19, scientists around the world are researching drugs to protect the body from viral infections, and a team of researchers from India at the Indian Institute of Technology (IIT) and other scientists are now finding hope in the petals of a Himalayan plant that they believe could be used to treat COVID-19.
Dr Shyam Kumar Masakaballi, associate professor of the study, said: “Among the therapeutic agents being studied, plant-derived chemicals are a particularly promising area due to their synergistic activity and natural source with few toxicity problems. ”
The team found that the petals of the Himalayan plant, called rosebush or rhododendron arboreum, are consumed by locals for their various health benefits.
Scientists are embarking on scientific tests of extracts containing various phytochemicals, with a particular focus on antiviral activity, to find that Himalayan plants are a promising candidate against COVID-19, with the results published in the journal Polymolecular Structures and Dynamics, "confirming that their results support the urgent need for further scientific studies in this area.
Print Email

Ashwagandha (Withania somnifera) is under a large clinical trial for Long COVID in the UK, where 2,000 participants take 500 mg twice daily for over a year, a program funded by the Ministry of Ayush and supported by WHO.

Title:

Content: Tuesday 10 August 2021 1:10 pm

Long Covid cure? Researchers to trial traditional Indian herb treatment

The London School of Hygiene & Tropical Medicine will work with the All India Institute of Ayurveda to determine whether a traditional Indian herb can help people recover from long Covid.

Ashwagandha, commonly known as Indian winter cherry, is traditionally used in the Indian Ayurvedic system of medicine to boost energy, reduce stress and strengthen the immune system.

Experts said recent trials had proven the herb’s efficacy in reducing anxiety, stress, improving muscle strength and reducing fatigue symptoms in patients with chronic diseases.

Long Covid patients can suffer from cognitive dysfunction, poor mental health, extreme fatigue and muscle weakness.

It is estimated these symptoms affect 10 to 20 per cent of Covid survivors and can last for one to three months or longer in many cases.

The study, funded by the Ministry of Ayush of the Government of India, will include a double-blind clinical trial involving 2,000 people living in the UK with long Covid.

Half of the trial participants will take 500mg Ashwagandha tablets twice a day for three months, while the other half will be given a placebo.

Researchers will randomly select participants to have a monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events.

The study is expected to last for over a year.

“Ashwagandha has been shown to reduce symptoms of other conditions that are similar to those of long Covid, so we are hopeful that it will be an effective way to combat the condition,” said Sanjay Kinra, professor in clinical epidemiology at the London School of Hygiene & Tropical Medicine.

The research is also supported by the UK’s All-Party Parliamentary Group on Indian Traditional Sciences and the Traditional Complementary and Integrative Medicine Unit at the World Health Organisation (WHO).

Research is the only way to ensure appropriate integration of traditional medicine knowledge into mainstream medical practice,” said technical officer at WHO Geneva, Geetha Krishnan, who helped to facilitate the research project.

Share

Green chiretta (Andrographis paniculata), used in South Asian herbal traditions, has been reported to achieve a 99.02% recovery rate in coronavirus cases and was approved by Thailand as an effective herbal treatment, although more studies are needed to verify efficacy and side effects.

Title:

Content: Coronavirus infection successfully treated with 'cheap and effective' herbal remedy

CATCHING coronavirus - whether you are vaccinated or not - can lead to a fever, coughing and feeling unwell. A mild infection has been shown to be eased by the use of a herbal remedy.

Link copied

Coronavirus in numbers: UK records 34,574 more cases

Green chiretta – a traditional herbal remedy used in Thailand – has been approved by the country's government as an "effective and cheap" herbal treatment to treat coronavirus. Thailand's government claims that a successful trial, conducted in prisons, shows that out of 11,800 inmates who took green chiretta to treat coronavirus, 99.02 percent recovered. Jail medic Chitsanuphong Saublaongiw said: "Green chiretta has a substance called andrographolide."

Saublaongiw explained that "the substance helps limit the spread of the virus".

He continued: "After taking green chiretta, the prisoners had better chest X-ray results, fewer symptoms, the disease was less severe, and they returned to normal quickly."

Thailand jails are reportedly overcrowded and cramped, according to Sky News.

Therefore, around a quarter of the country's prisoners tested positive for coronavirus in the six months from April 2021.

READ MORE: UK dubbed 'Putin's puppet' as gas prices fall after Russian offer

Coronavirus: Could a herbal remedy really help ease symptoms? (Image: Getty)

Around 141 jails around Thailand are reportedly planning to produce 38 million green chiretta tablets by November.

Thailand's minister of justice, Somsak Thepsuthin stated: "If we use modern medicine, the cost is 20 times, 30 times, 50 times higher...

"And in the prisons, it's very crowded. We must have [green chiretta] to treat people.

"If it's a mild illness, we can use this medicine, as it's inexpensive and effective."

DON’T MISS:

While Thailand's authorities have cleared green chiretta for use in mild cases, it is not a substitute for vaccination.

The herbal remedy does not prevent an infection with Covid and it is not suitable for severe cases.

Dr Mayuree Tangkiatkumjai, of the department of clinical pharmacy at Srinakharinwirot University, commented on the herbal remedy.

"Andrographolide is referred to as a substance found in green chiretta that helps suppress viruses and inflammation," he said.

Global coronavirus statistics (Image: Express)

"However, COVID-19 is still a new emerging infectious disease, so there is no sufficient research to confirm that green chiretta can prevent and cure COVID-19 yet."

Dr Tangkiatkumjai pointed out that "suitable" dosages of green chiretta "is still debatable".

In addition, further studies are needed to verify its efficacy and side effects.

Two more trials of green chiretta, involving 1,400 Covid patient with mild symptoms, is expected to be concluded by next spring.

UK coronavirus map (Image: Express)

What is green chiretta?

Green chiretta is a plant native to South Asian countries, said RxList – an online medical resource, owned by WebMd.

Its leaf and stem have frequently been used to prevent and treat the common cold.

Side effects can include loss of appetite, diarrhoea, vomiting, rash, headache, runny nose, and fatigue.

However, the herbal remedy is "likely safe" when taken in the short term.

Diabetes is a major application area, with studies indicating Ayurveda can help maintain blood sugar in type 2 diabetes with fewer side effects compared to some modern drugs, including the use of turmeric in care plans.

Title:

Content: News

Take up pilot project on Ayurveda treatment: MLA Ramdas

August 29, 2022

Mysore/Mysuru: Studies conducted across the world have found that several traditional medicines commonly used in India as part of Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Ayurveda is a traditional medical system that has been used for thousands of years in India and some of the herbs included are also used in other parts of the world. In this direction, a systematic project must be developed to treat diabetes, suggested MLA S.A. Ramdas. The suggestion was accepted by Ayurveda practitioners and experts in the field.

The MLA was speaking after inaugurating a free Ayurvedic treatment camp organised at the Sri Ganapathy Ashram on Nanjangud Road yesterday. The camp was organised inside the auditorium of Lakshminarasimha Kuteera of the Ashram by the Government Ayurvedic Research Centre and Ayurveda Academy of Chamarajpet in Bengaluru.

Ramdas suggested the doctors and officers launch a pilot project in a particular locality or a Ward and assured of making all facilities on behalf of the Government. He said that the project can be taken up on Sept. 17, the birthday of Prime Minister Narendra Modi for one year to achieve tangible results for the target population, he suggested.

Modern diabetes drugs are known for side effects and toxicity while Ayurveda works by controlling blood sugar and limiting the harmful effects of other drugs. Turmeric, for example, has been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine, he added.

He said new Ayurvedic remedies were still in great demand for treating diabetes because of the limited efficacy and undesirable side effects of current drugs. A multi-pronged and individualised approach must be used to manage health conditions such as lifestyle modification, Ayurvedic detoxifying and purifying therapies and Ayurvedic medicines containing plant, animal, or mineral-origin ingredients, he added.

University of Mysore Vice-Chancellor Prof. G. Hemantha Kumar, Assistant Director of Government Ayurvedic Research Centre Dr. Lakshminarayana Shenoy, Joint Secretary of Ayurveda Academy Dr. Prashanth Ghokale, Junior pontiff of Ganapathy Ashram Datta Vijayananda Theertha Swamiji and others were present.

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Print Editon: [email protected]
For News/Press Release: [email protected]

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

BGR-34 is an Ayurvedic formulation containing compounds from four medicinal herbs that has been reported to reduce blood sugar levels and address obesity, reflecting efforts to standardize multi-herb anti-diabetic formulations.

Title:

Content: Nation

Researchers claim 400 medicinal plants have anti-diabetic properties

X

New Delhi: As a part of its initiatives to reduce the diabetic burden, the scientists have emphasised on exploring the anti-diabetic properties of around 400 medicinal plants to be used in making medicines based on ayurvedic formulations to control type-2 diabetes by reducing sugar level in blood.

According to the researchers from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry and All India Institute of Medical Sciences, Kalyani, as of now, there are 21 herbal plants, including Vijayasar, Jamun, Cumin, Daruharidra, little gourd, bael, fenugreek, neem, amla, turmeric that have been found to have prominent anti-hyperglycemic action.

Stressing that diabetes cure lies in the nature, the researchers asserted that intensive studies have been done on 21 herbs and in-depth research on at least 400 herbal plants is needed to exhibit their anti-diabetic properties..

As per their research paper, which is published in the World Journal of Diabetes, these medicinal plants have been the basis of many drugs to manage diabetes. The researchers have also cited the example of BGR-34, a herbal formulation developed by the

Council of Scientific and Industrial Research (CSIR), which has been used to manage diabetes.

The herbal drug BGR-34 contains not one, but many active compounds derived from four medicinal herbs daruharidra, gudmar, methi and vijayasar. Apart from this, giloe and majeeth have also been added to increase immunity as well as antioxidants levels, said Dr Sanchit Sharma, executive director, AIMIL Pharmaceuticals.

The study titled “Treatment on Nature’s lap: Use of Herbal Products in the Management of Hyperglycemia” stated

that although partial research conducted on eight plants, including pomegranate, shilajit, bean, tea, ginkgo biloba, and saffron demonstrate anti-diabetic properties,

it emphasised the need for further trials.

A recent study conducted by AIIMS Delhi revealed that BGR-34, an Ayurvedic medicine, not only helps in reducing sugar levels but also addresses obesity.

The researchers also noted that several allopathic drugs used in diabetes management have their origins in herbal remedies.

For instance, metformin, a widely prescribed medication, is derived from the Galega officinalis plant, which

was historically used to treat diabetes in 19th century Europe.

Next Story

In what areas have the medical uses of traditional Indian medicine been studied?

Mechanistic research supports turmeric’s curcumin in improving insulin sensitivity and metabolic function, underpinning its anti-hyperglycemic role in diabetes management.

Title:

Content: Add 10 herbs to a glass of warm water and get the benefits
Saturday ، 29 June 2024 05: 00 AM
Add 10 herbs to a glass of warm water and get the benefits
I wrote Marwa Haridi.
Leave a comment and read the comments of the readers.
Insulin plays an essential role in regulating blood sugar levels by helping the absorption of glucose into cells to produce energy. Insulin is produced by the pancreas in response to elevated blood sugar levels after meals. Insulin sensitivity refers to how effectively cells respond to insulin signals, affecting how well glucose is absorbed from the bloodstream.
As cells become less sensitive to insulin, resistance occurs and the pancreas produces more insulin to compensate, which can lead to persistently high blood sugar levels and may lead to type 2 diabetes and other metabolic diseases, so maintaining or improving insulin sensitivity through regular physical activity, a balanced diet and maintaining a healthy weight is essential for overall metabolic health.
In the following..
Some spices known for their medicinal properties that can naturally repair insulin sensitivity, regulate blood sugar levels and help manage blood sugar, according to a report by Food-ndtv:
- Cinnamon.
Cinnamon is known for its ability to promote insulin sensitivity, improve glucose metabolism and lower blood sugar levels, as it contains biologically active compounds that mimic insulin and aid in the absorption of glucose by cells.
- Turmeric.
The active compound in turmeric, curcumin, provides powerful anti-inflammatory and antioxidant properties, may help improve insulin sensitivity, reduce insulin resistance and support overall metabolic function.
- Ginger.
Ginger is known for its ability to lower blood sugar levels and improve insulin sensitivity, it aids digestion, reduces inflammation, and supports metabolic health.
- The ring.
Fenugreek seeds are rich in soluble fiber, which slows the absorption of carbohydrates and helps improve insulin sensitivity, it may also lower blood sugar levels and improve glucose tolerance.
- Carnations
Clove contains compounds that may improve insulin function and help regulate blood sugar levels, and it also provides antioxidant properties that support overall health.
- Cumin
Cumin seeds help with digestion and regulate blood sugar levels by promoting insulin sensitivity and reducing inflammation in the body.
- Black pepper.
Piperine, the active compound in black pepper, helps absorb nutrients and may improve insulin sensitivity, it supports metabolic health and helps regulate blood sugar levels.
- Cardamom.
Cardamom helps improve insulin sensitivity and may lower blood sugar levels, aid digestion, and promote gut health.
- Nutmeg.
Nutmeg is thought to provide potential benefits for insulin imbalance due to its bioactive compounds, which include myristicin and eugenol, which may help improve insulin sensitivity and regulate glucose metabolism, which are essential for managing blood sugar levels.
- Coriander.
Coriander seeds contain compounds that may help improve insulin sensitivity and regulate blood sugar levels, they provide antioxidant properties that support metabolic health.
- Method of preparation of this component:
1 teaspoon cinnamon, turmeric powder, ginger, fenugreek seeds (ground), cloves (ground), cumin seeds, black pepper (ground), cardamom powder, coriander seeds (ground), bring a cup or two of warm water, put all the spices, stir well, let the mixture soak for a few minutes, then drain before drinking...

In what areas have the medical uses of traditional Indian medicine been studied?

Because native curcumin has low bioavailability, nano-formulations and the adjuvant piperine are being developed and studied to significantly enhance its oral bioavailability and therapeutic potential.

Title:

Content: Boosting curcumin's absorption and effectiveness for disease prevention and therapy

In a recent review published in the journal Antioxidants, researchers explored the potential of nano-formulations to boost the bioavailability and bioactivity of curcumin and its metabolites to amplify their antioxidant properties and disease-preventing effects potentially.

Study: Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment. Image Credit: tarapong srichaiyos/Shutterstock.com

Background

The roots of turmeric, containing the bioactive compound curcumin, have a long history of use in traditional medicine. Curcumin exhibits therapeutic potential in various diseases, including cancer, inflammation, and neurodegeneration.

However, its low bioavailability and rapid conversion to metabolites pose challenges. Curcuminoids, including curcumin, dimethoxycurcumin, and bisdemethoxycurcumin, display cellular regulatory effects with varying potencies.

Various nano-formulations have been developed to address curcumin's bioavailability limitations, aiming to enhance its stability and uptake.

They include nano-emulsions, micelles, exosomes, phospholipid complexes, liposomes, biopolymer nanoparticles, and nanostructured lipid carriers.

Researchers in the present review explore the effects of curcumin and its metabolites and nano-formulations' potential to amplify their disease-preventing actions.

Bioavailability of curcumin and curcuminoids

Curcumin undergoes significant metabolism in the liver and intestine, with limited distribution to other organs. Intraperitoneal administration demonstrates higher bioavailability than oral intake, which is particularly prevalent in animal studies.

Curcumin's bioavailability varies significantly, with plasma concentrations ranging from nanomolar to microgram levels. Factors like dose, duration, and mode of administration influence bioavailability across species.

Despite its poor water solubility, oral administration of curcumin in rats and humans revealed high concentrations and persistence in the gastrointestinal tract and colorectal tissue, demonstrating stability in the acidity of the stomach.

In cell culture, curcumin shows greater stability in the presence of serum- or blood-enriched media than in serum-free media. Cell-based studies highlight the importance of administration routes in optimizing curcumin levels.

Increasing the bioavailability of curcumin with nano-formulations

Diverse nano-formulations aim to enhance curcumin's bioactivity, leveraging improved solubility, stability, absorption routes, and co-administration strategies.

These formulations show promising outcomes in preclinical studies, with increased bioavailability, cellular uptake, blood-brain barrier permeability, and tissue distribution.

Nano-formulations present potential therapeutic applications across various diseases, including cardiovascular, liver, lung, neurodegenerative, cancer, metabolic, and gastrointestinal diseases.

Despite safety concerns associated with higher curcumin levels, most formulations demonstrate tolerability in clinical trials, emphasizing their potential to address diseases with inflammatory, oxidative stress, or aging components.

Antimicrobial action

Curcumin's antimicrobial efficacy is prominent in topical and oral applications, hindered systemically by higher minimal inhibitory concentrations.

Nano-formulations enhance antimicrobial potential, while curcumin-microbiota interaction supports intestinal health and reduces inflammation.

Regulatory effects of curcumin and its nano-formulations

Nanotechnology-based systems, including micelles, liposomes, and nano-emulsions, enhance curcumin's oral bioavailability, exhibiting improved absorption and stability.

Piperine, a natural agent co-administered with curcumin, significantly increases its oral bioavailability, demonstrating promise for enhancing the therapeutic potential of curcumin.

Combinations of curcumin with nano-formulations or bioactive compounds like quercetin, piperine, salsalate, and vitamin B6 show additive effects, providing effective strategies to augment curcumin's bioactivity and combat various conditions, including colitis and tumorigenesis.

Curcumin exhibits therapeutic potential for liver diseases, demonstrating anti-inflammatory, antioxidant, and anti-fibrotic effects.

Nano-formulations of curcumin show increased efficacy in treating conditions like non-alcoholic fatty liver disease (NAFLD), promoting lipid metabolism, and reducing inflammation.

Studies also explore curcumin's impact on adipose tissue, revealing its potential to inhibit adipocyte formation and ameliorate hepatic steatosis. Furthermore, under caloric restriction, curcumin supplementation, alone or with piperine, enhances fat loss and reduces inflammation in obese mice.

Curcumin’s nano-formulations promise to improve outcomes in myocardial infarction, ischemia, and hypertension.

Clinical trials suggest positive effects of curcumin on body weight, body fat, and metabolic markers in overweight/obese individuals, as well as in the prevention of cardiovascular diseases. Further research in clinical settings is warranted to optimize curcumin's anti-inflammatory effects in human chronic inflammation.

Formulations like galactomannan complexes and natural nanoparticles address Curcumin's limited brain uptake owing to the blood-brain barrier. They have shown neuroprotective effects on brain injury and ischemia.

In Alzheimer's disease, curcumin is found to inhibit amyloid-Aβ production and may influence tau protein aggregation, as seen in preclinical studies. However, clinical trial results on the cognitive benefits of curcumin nano-formulations vary, warranting further investigation into factors like treatment duration, formulation, and dosage.

Potential safe concentration range and toxicity of curcumin

Curcumin is proven to be safe and non-toxic in in vitro, animal, and human studies. No toxicity was observed in humans, even at high doses of up to 8 g daily for three months.

Curcumin nanoparticles also demonstrate safety in breast cancer models, and curcumin exhibits cardioprotective effects against chemotherapy-induced toxicity in both in vitro and in vivo studies, highlighting its versatile and well-tolerated nature.

Conclusion

In conclusion, advances in nanoscience have addressed curcumin's solubility issues, leading to nano-formulations with enhanced dispersion and therapeutic advantages.

Pre-clinical evidence consistently supports improved bioavailability and bioactivity, necessitating future human trials for optimized dosages and exploring combination therapies.

Comprehensive studies on the bio-interactions of curcumin with cellular structures are crucial to understanding the mechanisms behind the selective uptake of curcumin nanoparticles.

Journal reference:

Written by

Dr. Sushama R. Chaphalkar

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chaphalkar, Sushama R.. (2024, March 12). Boosting curcumin's absorption and effectiveness for disease prevention and therapy. News-Medical. Retrieved on March 12, 2024 from https://www.news-medical.net/news/20240312/Boosting-curcumins-absorption-and-effectiveness-for-disease-prevention-and-therapy.aspx.

  • MLA

    Chaphalkar, Sushama R.. "Boosting curcumin's absorption and effectiveness for disease prevention and therapy". News-Medical. 12 March 2024. <https://www.news-medical.net/news/20240312/Boosting-curcumins-absorption-and-effectiveness-for-disease-prevention-and-therapy.aspx>.

  • Chicago

    Chaphalkar, Sushama R.. "Boosting curcumin's absorption and effectiveness for disease prevention and therapy". News-Medical. https://www.news-medical.net/news/20240312/Boosting-curcumins-absorption-and-effectiveness-for-disease-prevention-and-therapy.aspx. (accessed March 12, 2024).

  • Harvard

    Chaphalkar, Sushama R.. 2024. Boosting curcumin's absorption and effectiveness for disease prevention and therapy. News-Medical, viewed 12 March 2024, https://www.news-medical.net/news/20240312/Boosting-curcumins-absorption-and-effectiveness-for-disease-prevention-and-therapy.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough research unveils β-cell dynamics in Type 1 diabetes

Integrative oncology is emerging, with Ayurveda used as complementary care, while tools like AYUSH QOL2C have shown improved quality of life in cancer patients receiving conventional cancer treatment.

Title:

Content: Home » In dialogue with great Ayurveda personalities / expert meeting at the 25th International Ayurveda Symposium in Birstein

In dialogue with great Ayurveda personalities / expert meeting at the 25th International Ayurveda Symposium in Birstein

by admin

Birstein – The International Ayurveda Symposium in Birstein (Hessen) is an annual highlight that every Ayurveda doctor, therapist and consultant should have on their agenda. From September 15th to 17th, 2023, doctors and professors of international renown will come together at the “European Academy for Ayurveda” to share their wealth of experience, this year for the 25th time in a row. Information at: www.ayurveda-symposium.org

The anniversary conference is filled with over 40 specialist lectures, workshops and panel discussions and stands for Ayurveda competence throughout Europe. Only here do the participants exchange ideas directly with the great personalities of Ayurveda and experience practical knowledge that is not found in any textbook.

For the 25th anniversary, the International Ayurveda Symposium takes up one of the major health issues of our time: strategies for the treatment and prevention of cancer. Research Director Vaidya P. Rammanohar (Amrita Center for Advanced Research in Ayurveda, Coimbatore) reports on how Ayurveda in integrative oncology can fill global unmet needs in cancer treatment. Prof. Dr. Tanuja Nesari, Director General of the Indian umbrella organization “All India Institute of Ayurveda” in Delhi, addresses phytotherapeutic approaches: Her lecture shows how traditional Ayurvedic medicinal herbs are used in complementary cancer therapy.

Ayurvedic therapists will appreciate the numerous workshops to supplement their practical skills. The focus here is on physical therapies, for example Kalari therapies from southern India or the combination of Ayurveda with osteopathic and chiropractic techniques. In addition, Hans H. Rhyner MD, pioneer of Ayurveda medicine in Europe, will pass on his very personal diagnostic methods from 40 years of practice to the next generation.

See also  Covid, the CDM unanimously launches dl with mandatory vaccine over 50

The focus on “Panchamabhuta – healing dimensions of the five elements” examines the influence of ether, air, fire, water and earth on our health. In particular, the connection to the five senses is the focus here, for example with the contribution of Dr. Mihir Hajarnavis (Tilak Ayurveda College, Pune) on the Indian tradition of eating with your hands, or treating hearing loss with oil baths (Karana Purana) by Prof. Sanjeev Sharma, Director of the National Institute of Ayurveda at the University of Jaipur.

The program is framed by the special flair on the campus of the European Academy for Ayurveda. Indian robes set accents in the stylish rooms, the lecturers give confidential insights into their careers at the fireplace evening – and scents from the Ayurveda gourmet kitchen float above everything, which brings the “five elements” closer to the participants in a culinary way.

In 2023, the symposium will only take place live and on site.
The opening event on Friday is open to all interested parties free of charge and will also honor the 30th anniversary of the academy with a ceremony. The alumni meeting with Gurukul is also free. SN Gupta, Vice-Chancellor Maganbhai Adenwala Mahagujarat University (Nadiad), will give professional and personal inspiration to former and current students at the “European Academy of Ayurveda”.

Date: September 15-17, 2023
Weekend ticket: €320 (€275 for alumni, students and DÄGAM/VEAT members)
Program and registration: www.ayurveda-symposium.org

About the European Academy for Ayurveda
Since 1993, the academy has followed its vision of bringing people into contact with traditional medicine from India. The founders Mark and Kerstin Rosenberg have created a place in Birstein where participants can learn and experience Ayurveda in all its facets: A modern educational facility has been created around a historic forester’s lodge in Vogelsberg (Hesse), with locations in Austria and Switzerland as well as a digital eAcademy. Close cooperation with Indian universities and institutions connect the academy with the source of Ayurvedic knowledge and ensure the quality of the educational offerings, as well as certification according to ISO 9001. A lively Ayurveda spa center borders directly on the campus. In this way, teaching and applied therapy go hand in hand – unique in Europe.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

What is the traditional Indian medical system called?

Beyond oncology, essential oils used in traditional Indian medicine demonstrate antioxidant, antimicrobial, and anticarcinogenic properties, suggesting broader preventive and adjunctive roles.

Title:

Content:
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

proofread

Researchers explore the molecular mechanisms and therapeutic potentials of essential oils

Essential oils, also known as ethereal oils, are volatile, aromatic compounds derived from plants. Found in only about 10% of the plant kingdom, these oils are present in secretory structures such as glands, ducts, cavities, and hairs. Chemically, they belong to categories such as terpenes, phenols, and nitrogen-bearing compounds, consisting of carbon, hydrogen, and other elements like oxygen, nitrogen, and sulfur.

Essential oils are valuable secondary metabolites with significant bioactive components, offering a range of therapeutic potentials. They play a protective role in plants against pathogens and have been used traditionally in various remedies for mental health and chronic diseases due to their rapid tissue penetration and broad spectrum of biological activities.

The composition of essential oils varies greatly depending on the plant species, geographic location, and . The primary methods of extraction include steam distillation, solvent extraction, cold pressing, and supercritical fluid extraction.

These methods influence the yield and purity of the essential oils, which in turn affects their therapeutic efficacy. The major components of essential oils, such as monoterpenes, sesquiterpenes, and their oxygenated derivatives, determine their biological activities.

Recent studies have highlighted the diverse biological activities of essential oils, including their antimicrobial, antiviral, anthelminthic, antioxidant, antiulcer, anti-inflammatory, insecticidal, larvicidal, and immunomodulatory effects. These properties make essential oils valuable in various industries, such as food, cosmetics, and pharmaceuticals. The therapeutic effects of essential oils are mediated through several , including their antioxidative, antimicrobial, anticarcinogenic, anti-diabetic, and .

Free radicals are responsible for , leading to lipid peroxidation and cellular damage, which can result in diseases like cancer, Alzheimer's, atherosclerosis, and Parkinson's disease. Essential oils demonstrate significant antioxidant activities by donating hydrogen or electrons to neutralize , thereby preventing oxidative stress and protecting cellular components.

The antioxidant potential of essential oils is often evaluated using in vitro methods like the Diphenylpicrylhydrazyl (DPPH) assay, which measures their free radical scavenging ability. In vivo assessments involve measuring levels of endogenous antioxidants like reduced glutathione, superoxide dismutase, and catalase, alongside nitric oxide levels. Essential oils enhance these antioxidant defenses, thus mitigating oxidative damage.

Essential oils exhibit potent antimicrobial properties, effective against a wide range of microorganisms. The antimicrobial mechanism involves disrupting microbial cell membranes, inhibiting enzyme activity, and interfering with microbial metabolism. These properties make essential oils suitable for applications in food preservation, medicine, and hygiene products. Notably, essential oils can disrupt the biofilms formed by bacteria, making them effective even against antibiotic-resistant strains.

The anticarcinogenic properties of essential oils are attributed to their ability to induce apoptosis (programmed cell death) and inhibit cancer cell proliferation. Essential oils achieve this by modulating signaling pathways involved in cell growth and survival, enhancing the activity of detoxifying enzymes like glutathione S-transferase, and promoting the degradation of carcinogens. This makes essential oils promising agents in cancer prevention and therapy. Some essential oils have shown the ability to inhibit angiogenesis (the formation of new blood vessels), which is critical for tumor growth and metastasis.

Essential oils also show potential in managing diabetes by modulating glucose metabolism and improving insulin sensitivity. They enhance the activity of glucose transporter proteins, reduce oxidative stress in pancreatic β-cells, and inhibit enzymes involved in carbohydrate digestion. These effects contribute to better glycemic control and reduced complications associated with diabetes. Essential oils like cinnamon and clove have shown promise in lowering blood glucose levels and improving lipid profiles in diabetic models.

Inflammation is a critical response to injury and infection but can lead to chronic diseases if unregulated. Essential oils exhibit anti-inflammatory properties by inhibiting the production of pro-inflammatory mediators like cytokines and prostaglandins. They also modulate the activity of enzymes such as cyclooxygenase and lipoxygenase, reducing inflammation and associated tissue damage. The anti-inflammatory effects of essential oils are beneficial in managing conditions like arthritis, inflammatory bowel disease, and other chronic inflammatory disorders.

The therapeutic applications of essential oils are vast, encompassing aromatherapy, topical applications, and oral formulations. In aromatherapy, essential oils are used to promote mental and emotional well-being. Topical applications leverage their antimicrobial and anti-inflammatory properties to treat skin conditions, wounds, and infections.

Oral formulations are explored for their systemic effects, including anti-diabetic, anticarcinogenic, and antioxidant benefits. The versatility of essential oils makes them suitable for integrative medicine, combining traditional practices with modern therapeutic strategies.

Despite the promising therapeutic potentials of essential oils, several challenges need to be addressed. The variability in composition due to different extraction methods and plant sources can affect the consistency and efficacy of essential oils. Standardization and quality control are essential to ensure the therapeutic effectiveness of essential oils.

Moreover, extensive research is needed to fully elucidate the molecular mechanisms underlying their biological activities. Future studies should focus on identifying the active compounds in essential oils, understanding their interactions at the molecular level, and exploring their synergistic effects.

Essential oils, with their diverse therapeutic potentials, offer promising avenues for treating various health conditions. Their antioxidative, antimicrobial, anticarcinogenic, anti-diabetic, and anti-inflammatory properties are mediated through complex at the cellular level.

Despite significant progress in understanding these mechanisms, comprehensive research is still needed to fully elucidate the fundamental actions of essential oils. Future studies leveraging systems biology approaches will be crucial in uncovering the intricate interactions and effects of within biological systems, ultimately enhancing their application in integrative medicine.

The work is published in the journal Future Integrative Medicine.

More information: Rakesh Kashyap, Exploring the Molecular Mechanisms and Therapeutic Potentials of Essential Oils: A Systems Biology Approach, Future Integrative Medicine (2024). DOI: 10.14218/FIM.2023.00071

Provided by Xia & He Publishing Inc.

Citation: Researchers explore the molecular mechanisms and therapeutic potentials of essential oils (2024, June 11) retrieved 11 June 2024 from https://phys.org/news/2024-06-explore-molecular-mechanisms-therapeutic-potentials.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Aromatherapy use and safety: What to know about essential oils during pregnancy

0 shares

Feedback to editors

Mental health and rehabilitation are active fronts for Indian herbal medicine, with Ashwagandha repeatedly shown to reduce anxiety and stress, partially via GABAergic pathways and anti-inflammatory effects, and to improve muscle strength and reduce fatigue.

Title:

Content: Ashwagandha leaf extract is derived from the Withania somnifera plant and is thought to have an array of benefits. You’ve probably seen it in your local health store in pill form but understanding a compound that is difficult to pronounce might have you baffled as to the benefits.

That said, ashwagandha is a mainstay of many people’s lifestyle, and potentially with great reason. M&F takes a closer look at some of the current research around this exciting substance.

Ashwagandha is not an easy word to pronounce, but you probably also know this compound by the name ‘Indian Ginseng.’ It’s usage dates back more than 3,000 years, and even in this modern era, we are learning that some of those obscure plants used back in the day may be legit. Science seems to agree: in conventional medicine categorization, ashwagandha is labeled as an adaptogen, meaning that it is a naturally occurring substance that may help to rejuvenate the body. While there are a bunch of unfounded claims that are made by marketers for all types of modern supplements, here are five things we know about the awesomeness of ashwagandha.

Improved Sleep Quality (and Quantity)

A systematic review of ashwagandha dosed between 120mg and 600mg per day found that not only did participants fall asleep faster, but they had less waking events and their perceived sleep quality improved as well, meaning that the individuals taking ashwagandha likely felt better refreshed to tackle the day ahead. According to research, ashwagandha affects receptors of the neurotransmitter; GABA, and this would explain why it might be so good at promoting some shuteye. It is important to note however, that most studies have been carried out on otherwise healthy people. Work to determine whether if it is a suitable treatment for those with insomnia is currently ongoing.

Ashwagandha Contains Anti-Stress/Anxiety Compounds

The active ingredients in ashwagandha are known as ‘withanolides’. These are naturally occurring compounds that are thought improve our mental health. Reviews have found that ashwagandha (Withania somnifera) “exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies.” Results have also shown that ashwagandha may alleviate cases of depression, too. It is thought that the leaf extract modulates pathways in the brain, leading to overall better mental wellbeing.

Increased Testosterone & Sex Hormone Levels

A study conducted in 2015 found that men supplementing with 300mg of ashwagandha root twice per day had increased testosterone levels by an average 96.2 nanograms per deciliter, much higher than the placebo group of 18 ng/dL. Additional studies on infertile men have also found that 5g of ashwagandha root powder daily for 3 months showed increased levels of sex hormones such as luteinizing hormone, and a higher sperm count to boot. Numerous other studies all support ashwagandha’s ability to increase levels of testosterone and fertility. 600 mg per day for a 12-week period was shown to produce up to 1.7 times increased muscle strength and up to 2.3 times muscle mass.

Reduced Inflammation

Research has found evidence that one of this compound’s many benefits include the fact that it exhibits anti-arthritic, pain-relieving qualities. In both animals and humans, studies have shown decreased swelling, a slower degradation of skeletal joints, less pain, and overall better mobility among patients that supplemented with the leafy stuff. While this type of research is still in the early stages, it does bode well for future applications. Ashwagandha is also showing promising results for those who suffer with osteoarthritis, but there’s more work to be done.

Ashwagandha Isn’t a Fad Product

Unlike many empty supplements that have only bro-science to prop them up, ashwagandha is becoming a tried and tested compound that could benefit your body and mind. As with all changes to your diet and nutrition, it is advisable to seek the advice of a medial professional before making any drastic changes.  For the average person, 500 mg per day seems to be a well-tolerated dosage limit although this will depend on the individual, and any other medications that you may be checking. Always do your research on how a given supplement will interact with your current medication to be on the safe side, but never discount a potentially beneficial compound just because it’s not the latest product on the shelf.

In what areas have the medical uses of traditional Indian medicine been studied?

Treatment on neurological conditions
Treatment on mental health disorders

What does traditional Indian medicine generally treat?

It addresses the psychological aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

A large randomized program is testing Ashwagandha for Long COVID–related fatigue and anxiety, reflecting growing interest in mind–body–herbal integrative strategies.

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the psychological aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

Other reported applications include ophthalmology claims from Dr Basu Eye Hospital, where herbal eye drops were reported to improve vision in cataract and glaucoma patients, though these findings are based on institutional reports and warrant independent verification.

Title:

Content: Sign In
  • ENG

Herbal Eye Drops Can Cure Cataract And Glaucoma, Says Dr Mahender Singh Basu

Dr Mahender Singh Basu, Founder of Dr. Basu Eye Hospital speaks on herbal eye drops as an effective cure for many serious eye problems

Written by Kinkini Gupta |Updated : March 24, 2023 1:52 PM IST

A press conference was held on 23rd of March to address the importance of herbal eye drops that have been proven to be able to cure many complicated eye problems. The doctor who was present in person to talk about their research and study was, Dr Mahender Singh Basu, the Founder of Dr. Basu Eye Hospital and the other experts was also present virtually was Prof. Yamini Bhushan Tripathi, Head of Faculty, Faculty of Ayurveda, Banaras Hindu University. Their research on these eye drops has also been published in the International Journal of Pharmaceutical Sciences and Research. Doctor Basu said during his speech at the press conference that these drops have been clinically tested and all of them have showed positive results in patients. These drops were tested on lakhs of Indians and are also available in the market.

Their study on the effectiveness of these eye drops included 308 cataract patients between the year 2017 and 2019. The results of the study were very positive and people showed significant improvement in uncorrected distance visual acuity (UDVA) and uncorrected near visual acuity (UNVA).

Conclusions Of The Study

Patients used the herbal eye drops for about three months after which they showed improvements in their vision. Doctor stated that there was a major improvement in the near-sightedness and far-sightedness of the patients. All of these patients who showed improvements used to were spectacles before but after using the eye drops; they were able to see without them. This constitutes about 91 per cent of the people from two experiment groups. Moreover, among the patients in the third experiment group, 47 per cent of them showed decrease in their glaucoma power and 61 per cent of the patients in the fourth group were able to regain their eyesight to some extent.

Also Read

More News

Doctor Basu Says There Is No Pressure Of Side Effects

When asked about the eye drops, its effectiveness and side effects, Dr, Basu mentioned that these eye drops have been clinically tested and tried and there have not been any side effects and he concluded by saying that these drops do not have side effects that patients need to worry about.

He also said that, these drops can be used without a medical prescription and it can be used by people with a range if eye problems like, cataract, glaucoma, eye itchiness, eye allergies, eye strain due to excessive technology use. These drops are beneficial for complicated and regular eye problems alike.

Total Wellness is now just a click away.

Follow us on

Traditional therapies are also used for musculoskeletal and sensory disorders, and some centres combine Ayurveda with osteopathic and chiropractic techniques in integrative practice.

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

What is the traditional Indian medical system called?

Digital health and hybrid care models are accelerating access to integrative therapies, exemplified by RaphaCure’s partnership with Madhavbaug to deliver preventive cardiac care using Ayurvedic protocols through telemedicine and remote patient monitoring.

Title:

Content: RaphaCure partners with Madhavbaug to enhance access to Cardiac Healthcare Services in India

RaphaCure company logo

Madhavbaug image

Cognota Healthcare Pvt. Ltd.

Madhavbaug is India’s leading cardiac care service provider leveraging the amalgamation of Ayurvedic treatments and modern medical science

We are excited to partner with RaphaCure for enhancing Madhavbaug’s digital healthcare solutions. This tie-up is a giant leap for making non-invasive care accessible for masses in remote regions.”
— Dr. Rohit Sane
BENGALURU, KARNATAKA, INDIA, January 24, 2022 /EINPresswire.com/ -- Leading digital healthcare services provider, RaphaCure on Monday said it has entered into a strategic partnership with Madhavbaug (Vaidya Sane Ayurved Laboratories Limited), India’s most prominent chain of clinics and hospitals in the cardiac care space leveraging the amalgamation of Ayurvedic treatments and modern medical science.

Madhavbaug (Vaidya Sane Ayurved Laboratories Limited) has a pan-India presence with a vast network of 272 clinics and two hospitals. With more than a decade of expertise in preventive cardiology, the healthcare company is a pioneer in non-invasive cardiac care in the world.

This strategic tie-up is a game-changing event for the cardiac care space wherein technology will be leveraged to reach out to patients even in the remotest regions of the country. RaphaCure and Madhavbaug will not only play to each other’s core strengths but will also tap their combined network for providing better patient care. Moreover, the partnership opens up new pathways for people to access ancient Ayurvedic Care which is India’s pride and heritage.

RaphaCure is powered by Cognota Healthcare, which is a leading healthtech company with multiple cutting-edge digital solutions. Together with RaphaCure, Cognota’s teleconsultation platform and Remote Patient Monitoring (RPM) solution is bringing in a paradigm shift in the Indian healthcare landscape. With this partnership with Madhavbaug, the duo will now bring the Indian system of medicine to patients’ doorsteps.

Commenting on this strategic collaboration, (Vaidya Sane Ayurved Laboratories Limited) Madhavbaug’s Founder, MD & CEO Dr. Rohit Sane said,” We are excited to partner with RaphaCure for enhancing Madhavbaug’s digital healthcare solutions. Recently in an event to inaugurate Madhavbaug Power MAP (a Digital Medical Analysis Application), Hon. Min. Shri Nitinji Gadkari encouraged Madhavbaug to extend chronic cardiac Healthcare solutions to low socio-economic classes and those living in remote areas through innovative technologies like Power MAP. This tie-up is a giant leap for making non-invasive care accessible for masses in the remote regions of the country through Raphacure-Cognota technology platform.”

Hailing the partnership as a breakthrough, Founder and MD of RaphaCure, Jeyakumar said, “As we move ahead, RaphaCure & Madhavbaug (Vaidya Sane Ayurved Laboratories Ltd) will complement each other in taking the path-breaking non-invasive cardiac care treatments to every nook and corner of the country. Leveraging our telemedicine platforms, Madhavbaug will expand its patient care reach further as we tap into each other’s network. With a great synergy in our operations and objectives, we will strive to take preventive cardiac care to the next level.”

Telemedicine adoption is growing at a rapid pace in India. A recent EY study estimates the market size to reach $5.5 billion by 2025.

“Indian healthcare ecosystem is digitalising at a rapid pace with telehealth seeing the highest adoption amid the pandemic. The collaboration between RaphaCure & Madhavbaug (Vaidya Sane Ayurved Laboratories Ltd) is a testimony to the fact that technology plays a crucial role in making this happen. As they leverage Cognota Healthcare’s multiple digital platforms to reach out to the remotest region of the country, we stay committed to integrating most advanced features that make this process seamless with utmost focus on client privacy and confidentiality,” said Sanjeev Dahiwadkar, Founder & CEO of Cognota Healthcare.

For more information contact us:

Tanvi Saha, Sr Manager- Client Relations
Cognota Healthcare Pvt Ltd.
Email: tanvi.s@cognotahealthcare.com
Contact: +91 8080447312
Linkedin

Madhavbaug (Vaidya Sane Ayurved Laboratories Ltd)
Dr. Suhas V. Dawkhar
Email: drsuhas@madhavbaug.com

Nanda Kumar
RaphaCure
+91 99676 48845
email us here

What is the traditional Indian medical system called?

The telemedicine push reflects India’s broader trend of leveraging technology to extend non-invasive, integrative care into remote regions.

On the research side, India’s National Medicinal Plant Board maintains data on hundreds of medicinal plants, strengthening the resource base for drug discovery and standardization efforts.

Title:

Content: Govt to document medicinal herbs of tribal communities

Centre to document medicinal herbs of tribal communities across country

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand

The Centre is working on documenting medicinal herbs and healers of the tribal communities across the country. A pilot from Uttarakhand has been completed, resulting in a five-volume book series of over 1,400 medicinal plants. The exercise, officials said, will be carried out in more states.

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand. Apart from documenting the plant and healers, they also documented the Sanskrit names of these plants.

In Kerala, the Amrita Vishwa Vidyapeetham was given the responsibility, All India Institute of Medical Studies Jodhpur in Rajasthan, Pravara Institute of Medical Sciences Ahmedabad for Maharashtra, and Patanjali carried it out in Uttarakhand.

While the others are carrying it out, Patanjali’s series of seven tomes are ready. In the hill state three districts were chosen, which included Pithoragarh and Udham Singh Nagar, all phytodiversity was documented by a team of over 50-50 people over a period of two years.

When asked about the Sanskrit nomenclature, the official said that it was a way of directing attention to the functionality of the plant.

“The National Medicinal Plant Board says there are over 1,500 plants in Uttarakhand, many of which are not even documented. But in three districts alone, we found 900 plants,” a senior official of the ministry said. “Tribal medicine holds considerable interest among researchers.”

Chemical analysis of all these plants was carried out, to find the active ingredient in the plant, with the help of an HPLC machine, officials said. Apart from that, samples of these were preserved, along with data on their therapeutic use. The official said that permissions from the biodiversity board were also taken.

In addition to that, the Hyderabad-based National Institute of Pharmaceutical Education and Research (NIPER) carried out a similar exercise in their areas where they found three medicinal plants, which when combined can be a cure for malaria. A similar exercise was carried out by the same team in the Rashtrapati Bhawan as well.

Healers in tribal communities in the areas that use these plants were also documented, along with data of their areas of expertise. In all, 750 healers were documented.

Officials said that after the successful pilot, the ministry has sent it to the AYUSH ministry, urging them to take it further across the country using SC/ST components from their funds. Officials also said that details of these plants will be put up online.

Check out DH's latest videos

Check out DH's latest videos

Get a round-up of the day's top stories in your inbox

Check out all newsletters

Get a round-up of the day's top stories in your inbox

Quality, safety, and regulation are central to scaling Indian herbal medicine responsibly, and India has created a regulatory pathway for plant-based drugs called phytopharmaceuticals to bridge traditional knowledge and modern drug standards.

Title:

Content: Explainers
NEWS
12 hours ago

Does India Have Patience, Will And Resources To Build World's Top Cannabis Medicine Industry?

Raghav PriyadarshiUpdated on Mar 27, 2022, 16:03 IST

Consider the size of the opportunity — today’s billion dollar global medical cannabis industry is expected to hit USD 100 billion by 2028. That’s a 100x growth in the next six years.

We’ve missed the bus once — India is the largest producer and exporter of licit opium in the world, contributing over 50% of global volumes. Yet there is not a single Indian firm that is a global leader in manufacturing opioid medications, a USD 40 billion market annually!

Unspash/Representational image

On the back of successful medical cannabis regimes in countries such as Canada, Germany and increasingly the United States, hundreds of thousands of patients are able to access medical cannabis to treat a host of chronic conditions, most of which do not have safe or effective treatment pathways – neuropathic pains such as sciatica, fibromyalgia, and cancer-related pains; rheumatic conditions such as arthritis and multiple sclerosis; neurological conditions such as insomnia, migraine and Parkinson’s; or the ever increasing burden of mental health issues such as anxiety and depression – all conditions in which cannabinoid medicine has demonstrated ground-breaking results.

In this scenario, it is important to remember and highlight that India has the oldest medical cannabis regime in the world – in the form of Ayurveda – which records over 200 classical cannabis-based formulations. While Ayurveda recognises cannabis as a medicinal plant, allopathy does not.

Thus, modern formulations containing cannabis compounds cannot be manufactured and marketed with approvals from India’s drug regulator, until clinical research establishes the safety and efficacy of cannabis compounds in treating any particular condition. The onus is thus on the Indian pharmaceutical industry to undertake the required research to establish cannabinoids as therapeutic agents.

Unsplash/Representational image

Plant-derived drugs have tremendous potential, and the global pharma industry has barely scratched the surface of developing modern therapeutic formulations from medicinal plants. A case in point is ‘Artemisinin’, first extracted from Sweet Wormwood by Tu Youyou, a Chinese chemist who was awarded the Nobel Prize for Medicine in 2015 for demonstrating the efficacy of Artemisinin in treating malaria.

Tu Youyou drew inspiration from Traditional Chinese Medicine texts to find a cure for malaria, texts which prescribed using Sweet Wormwood to treat various fevers. Similarly, India too enjoys a unique position to build on the thousands of years of traditional medical knowledge contained in Ayurveda, to create novel therapeutics for unmet medical needs of the 21st century.

Cannabinoid medicine is projected to be the fastest growing life-sciences sector over the coming decade. Tapping this opportunity requires a change in mindset of Indian pharma, graduating from generic medicine manufacturing to R&D-based novel drug development. India has the necessary ecosystem – scientists, clinicians, researchers, a large drug manufacturing ecosystem and very large patient population – to really catapult the Indian life-sciences industry, and in particular cannabinoid therapeutics firms into global leaders.

Unsplash/Representational image

Cannabinoids have the potential to capture a significant share of this market with safer and effective alternatives to opioids and other analgesic medicines. The Indian drugs regulator has even issued regulations for a new class of plant-based drugs – ‘phytopharmaceuticals’ – a perfect bridge between traditional medicine manufacturing and modern allopathy.

Yet, seven years after the establishment of this hybrid regulatory regime, the Indian pharmaceutical industry is yet to respond with novel formulations registered under this category of medicine. It is high time we change our mindset, focus on value-added drug development, play by the rules of global pharma with respect to quality, safety and efficacy standards, and win!

The author is the founder and Chief Executive Officer of Savikalpa Sciences, a cannabinoid-focussed pharmaceutical firm. The views expressed in the article are author's own.

The Ministry of Ayush has warned manufacturers against misleading claims, while the National Pharmacovigilance Centre monitors safety under the Drugs and Cosmetics Act.

Title:

Content: Active Stocks
Fri Apr 26 2024 15:54:22
  1. Tata Steel share price
  2. 165.85 -1.04%
  1. Kotak Mahindra Bank share price
  2. 1,608.40 -2.11%
  1. Wipro share price
  2. 464.65 0.79%
  1. ITC share price
  2. 439.95 0.56%
  1. Tech Mahindra share price
  2. 1,277.45 7.34%
Business News/ News / India/  'Misleading claim will attract...': Ayush ministry warns ayurvedic drugmakers after Patanjali's ads debacle
Back

'Misleading claim will attract...': Ayush ministry warns ayurvedic drugmakers after Patanjali's ads debacle

An advisory, reportedly issued by the Ayush ministry, issued a warning related to products that make unsubstantiate claims or display false information, such as featuring a green logo.

The Ministry of Ayush reportedly issued a warning to all Ayurvedic, siddha, unani, and homoeopathic drugmakers after the Supreme Court pulled up Patanjali Ayurved Ltd in connection with a misleading advertisements case.

According to News 18, the Ayushi ministry issued the warning, asking the drugmakers to "strictly comply with labelling and advertising regulations". Failing to adhere to regulations may attract legal action, the report added.

The clarification by the ministry was accessed by News 18, the report said, adding that the warning was related to products that make "unsubstantiated" claims or display false information, such as featuring a “green logo" claiming to be “100% vegetarian" or falsely stating that the drug is “approved or certified by the ministry".

ALSO READ: Patanjali in court: SC pulls up company, warns FMCG firms against misleading ads

Any misleading claim or advertisement in any form or on any platform will attract consequent legal actions by the competent authorities," the advisory was cited by News 18. The advisory also mentioned details about all laws and rules that cover misleading advertisements in the country.

The ministry reportedly ordered state drug licensing officials to examine all such drugs claiming to be “certified or approved by Ministry of Ayush" – either on their labels or in the advertisements. It further asked the officials to ensure compliance.

ALSO READ: Patanjali pulled up by the SC: Truth matters in advertising

'Ayush ministry has no role in granting manufacturing licences'

The advisory said licensing by the state drug licensing authority “shouldn’t be construed as an approval by the Ministry of Ayush", the report added.

“It has come to the notice of the Ministry of Ayush that some Ayush drug manufacturers are mentioning 'certified or approved by Ministry of Ayush' on the label of their drug or product or in the advertisement in print, electronic media,' the notice reportedly read.

ALSO READ: Patanjali ads cast a long shadow over FMCG sector

News 18 further reported that the ministry clarified it has no role in granting manufacturing licences or approvals to any Ayush drug or product.

It even cautioned that going forward, any such claim on the label or advertisement will attract “consequent legal action against the alleged manufacturer by the Ministry of Ayush".

ALSO READ: 'Apology only after...': Supreme Court rejects Ramdev's apology in Patanjali misleading ad case

The advisory further added the licence issued by a state authority is only permission to manufacture or sell a particular drug or product based on the fulfilment of conditions under the Drugs and Cosmetics Act, 1940.

The advisory was also sent to the National Pharmacovigilance Coordination Centre, which monitors and designs drug safety profiles, including the release of alerts, in case any drug is reporting new side effects.

ALSO READ: Baba Ramdev, Acharya Balkrishna tender unconditional apology for misleading Patanjali ads

According to News 18, the Centre was asked to “ensure reporting of such claims of approval or certification by Ministry of Ayush to concerned State Licensing Authority, under intimation to this Ministry of Ayush".

The warning came after Yoga guru Ramdev and his aide Balkrishna of Patanjali Ayurved Ltd tendered an "unconditional and unqualified apology" before the Supreme Court over advertisements issued by the firm making tall claims about the medicinal efficacy of its products.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 27 Apr 2024, 06:58 PM IST
Next Story
Recommended For You

India is revising Schedule M to align Good Manufacturing Practices with WHO standards and has mandated GMP adoption across the industry, steps designed to strengthen quality control.

Title:

Content: Schedule M likely to be revised to bring it closer to WHO standards

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India

Anjali SinghSanket Koul New Delhi/Mumbai

4 min read Last Updated : Oct 1 2023 | 7:49 PM IST

A notification for revising Schedule M (of the Drugs and Cosmetics Rules, 1945) may be released soon to help Indian pharma companies adopt good manufacturing practices (GMP) as prescribed by the World Health Organization (WHO), a senior government official said.

The Drugs Controller General of India (DCGI), Rajiv Singh Raghuvanshi, said at a conference revised Schedule M would bring the industry on a par with global standards.

The move has come after the WHO raised concern when cough syrups exported by some Indian companies were allegedly responsible for the deaths of children abroad.

Adopting GMP in accordance with revised Schedule M was made mandatory for all pharma companies, including micro, small and medium companies, last month. Manufacturers having an annual turnover of less than Rs 250 crore had to complete their certification process within 12 months, whereas those with over Rs 250 crore were given six months to do so.

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India.

Meanwhile, to explain these changes and ensure compliance with them, the Central Drugs Standard Control Organisation (CDSCO) has conducted a one-day workshop in Mumbai.

Eswara Reddy, joint drug controller, CDSCO, said one of the most important changes proposed in the new draft rules was introducing a comprehensive system for change control.

“Under the current rules, manufacturers are only required to notify the CDSCO of significant changes to their manufacturing processes. The new draft rules would require manufacturers to classify all changes as minor, major, or critical, and to implement appropriate controls for each type of change. This would help to ensure that any changes in manufacturing processes are evaluated and managed to minimise the risk of product contamination or quality problems,” Reddy said.

The revision introduces the pharmaceutical quality system, quality risk management, product quality review, and qualifying and validating equipment, change control management, self-inspection, and stability studies in accordance with recommended climate conditions. Another important change proposed in the new draft rules is that manufacturers need to have a qualified and validated computerised storage system for all drug products, ensuring that drugs are stored in right conditions and that their quality is maintained throughout the supply chain. The draft rules also introduce validated cleaning procedures, working standards, and identity tests for starting materials. Additionally, they extend the retesting period for materials and call for including weighing areas, audit trails, and measures to prevent cross-contamination. Detailed guidelines for good production practices, deviation control, and equipment storage after cleaning have also been incorporated.

The ongoing risk-based inspections might have prompted the government to reassess the current GMP regulations and quality management systems followed by pharmaceutical manufacturers.

GMP, which include standards for materials, methods, machines, processes, personnel, and facilities, was first introduced in 1988 under Schedule M. This is the first amendment since June 2005.

The government has been trying to implement regulatory reforms in the pharma sector for the past few months. This includes regular meetings with state controllers to ensure harmonisation in the workings of the departments. Highlighting India’s desire to be a permanent member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, the DCGI said: “We have been accorded observer status but the ball is in their court as far as inviting us for membership is concerned.”

The DCGI said 99 per cent of the spurious products found during the past two to three years were among the top 300 medicine brands in India.

To counter this, the CDSCO will develop a digital regulatory ecosystem to look into grievances and impacts caused by the spurious industry.

The CDSCO has raided several labs that made spurious medicines.

Topics :World Health OrganisationPharma CompaniesMSMEspharmaceutical firms

First Published: Oct 1 2023 | 7:38 PM IST

Next Story

The government has also issued new standards requiring companies to test ingredients before marketing finished products, and recent inspections highlighted quality gaps that must be addressed within tight timelines.

Title:

Content: World News
India orders new standards for pharmaceutical manufacturing
ABU DHABI (Reuters) - India ’ s pharmaceutical companies must set new manufacturing standards this year, according to a government notice issued on Saturday.
The notice, dated December 28, states: “The manufacturer must take responsibility for the quality of the products to ensure they are suitable for their intended use, comply with licensing requirements and do not put patients at risk. ”
The notification added that companies must market the finished product after achieving “satisfactory results ” in testing the ingredients.
India ’ s health ministry said in August that inspections at 162 pharmaceutical plants since December 2022 had revealed a “lack of testing for incoming raw materials. ”
Fewer than a quarter of India ’ s 8,500 small pharmaceutical factories comply with international standards for the manufacture of medicines set by the World Health Organization (WHO), the ministry said.
The notification stated that these concerns should be addressed by major pharmaceutical companies within six months and by small manufacturers within 12 months.
Advertisements
You may also read.

Regulators report instances of substandard products and are augmenting oversight, including risk-based inspections and market withdrawals when quality parameters fail.

Title:

Content: 11 of 59 substandard drugs from Himachal : The Tribune India

Spurious Drugs

11 of 59 substandard drugs from Himachal

Uttarakhand on top of list with 15

Tribune News Service

Ambika Sharma

Solan, March 31

Uttarakhand has topped the list of substandard drugs with 15 of its drugs figuring in the list of 59 drugs declared substandard by the national drugs regulator, the Central Drugs Standard Control Organisation, today. Himachal is second with 11 of its drugs figuring in the list.

Firms to be put on notice

  • Substandard drugs to be withdrawn, firms to be issued show-cause notices, says drugs controller
  • Used for treating bacterial infections, acidity, pneumonia, liver disease, hypertension, diabetes
  • Issues in assay content, dissolution & uniformity of weight behind drugs failing to meet quality parameters

Of the 1,251 drug samples tested from various states, 1,192 were declared of standard quality, while 59 were found lacking in quality nationally.

Seven drugs manufactured in Sikkim, six in Uttar Pradesh, three each in Madhya Pradesh and Gujarat, two each in Andhra Pradesh, Delhi, Karnataka and Bengaluru, and one each in Haryana, Punjab, Telangana, Puducherry, Tamil Nadu and Maharashtra also figure in the list, besides one from Bangladesh.

Navneet Marwaha, State Drugs Controller, said batches of drugs figuring in the list would be effectively withdrawn and the firms would be issued show-cause notices to identify the cause.

He said 10 drugs had been declared substandard, while one was a spurious drug manufactured by some firm in the name of Aristo Pharmaceuticals, Baddi.

He said they were continuously monitoring the drug quality and several firms were jointly inspected in risk-based inspections by the state and central authorities. Firms had been educated to upgrade their facility to meet the norms.

Drugs from pharmaceutical firms in Himachal which could not meet quality parameters are used for treating bacterial infections, acidity, for improving bone strength, pneumonia, liver disease, hypertension, diabetes and infection caused by worms. Issues in assay content, dissolution and uniformity of weight were among the major causes attributed to the drugs failing to meet the quality parameters. They affect the efficacy of the drug.

Firms whose samples were found lacking in quality are Events Corporation, Kala Amb; Healers Lab, Baddi; Terrace Pharmaceuticals, Sansarpur, Kangra; Aristo Pharmaceuticals, Baddi; Zee Laboratories, Paonta Sahib; Aishwarya Healthcare, Baddi; Unital Formulation, Baddi; Park Pharmaceuticals, Baddi; Quixotic Healthcare, Baddi; Cosmas Pharmacls, Barotiwala; and Spas Remedies, Baddi,

Ventoxen tablet manufactured in the industrial area at Kanchpur, Bangladesh, too figures in the list.

#Uttarakhand

Tribune Shorts

Top News

Navjot Singh Sidhu walks out of jail after 10 months

Former PPCC chief addresses media outside Patiala Jail

Delhi Police file chargesheet in Kanjhawala hit-and-drag case

Metropolitan Magistrate Sanya Dalal has posted the matter fo...

Son Karan says Navjot Sidhu will first go home to see his wife who is suffering from cancer

Karan says happy to see father coming out of jail, last 10 m...

Nakkiana toll plaza on Kiratpur Sahib-Nangal-Una road in Punjab closed

Bhagwant Mann says it is the eighth toll plaza shut down by ...

Sikh shopkeeper shot dead in Pakistan's Peshawar

Dyal Singh, 35, was killed on the spot

Cities

View All

India has allocated $80 million to strengthen the drug regulatory system after quality lapses, including global incidents that underscored the need for robust manufacturing and surveillance.

Title:

Content: In India, of the nearly 89,000 drug samples tested, more than 2,500 failed to meet the standards.
Such data was presented by the Minister of health of the country Mansuh Mandavia, reports Reuters.
About 380 samples were found to be fakes.
The government of India has allocated about $80 million to the Ministry of Health to strengthen the drug regulatory system, including the creation of laboratories for testing new drugs and the modernization of existing ones.
Over the past 10 years, exports of pharmaceuticals from India more than doubled to $24.5 billion in 2021-2022.
However, the deaths of 20 children in Uzbekistan and 200 in the Gambia and Indonesia after taking children's antipyretic syrups from Indian companies, in which ethylene glycol was found, undermined India's image as a "world pharmacy," the newspaper notes.
Last week, the Indian manufacturer Global Pharma Healthcare was also forced to withdraw all batches of its eye drops, as the United States registered 55 cases of side effects associated with taking the drug, including eye infections, irreversible loss of vision and one death, writes The Hindu BusinessLine.
At the end of January, the World Health Organization called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.
Governments should enact laws to combat substandard and falsified medicines and strengthen market surveillance, including informal surveillance.

India is also pursuing international standardization by seeking Ayurveda’s inclusion in WHO’s ICD-11 and enhancing adverse event reporting through the National Ayush Morbidity portal.

Title:

Content: Traditional Indian medicine set to make a global debut, seeking inclusion in WHO’s ICD-11 list

The inclusion of Ayurveda and related systems on the WHO list will provide it with a common language that allows health professionals to share standardised information across the world

October 14, 2023 06:17 pm | Updated 06:17 pm IST - NEW DELHI

A view of the World Health Organisation headquarters.

In a move meant to put the Indian system of medicine on the world map and provide it with a common standardised language, the Union government has sought for Ayurveda and related systems to be included in the 11th revision of the World Health Organisation’s International Classification of Diseases (ICD), as the second module of a supplementary chapter on traditional medicine conditions.

The ICD provides a common language that allows health professionals to share standardised information across the world. The traditional medicine module of the 11th revision provides a list of diagnostics categories to collect and report on traditional medicine conditions in a standardised and internationally comparable manner.

Speaking exclusively to The Hindu about the development, Ministry of Ayush Secretary Vaidya Rajesh Kotecha said: “We are hopeful that the addition of Module-2 for Ayurveda could happen as early as by next January.”

To aid regulation, research

“Ayurveda and related Indian traditional health care systems are formally recognised and widely practised health care systems in India, which is making a strong and valid point for its inclusion,” said Mr. Kotecha, adding that efforts to effectively regulate traditional medicine as an integral part of the health system require standardised and evidence-based information.

Mr. Kotecha further explained that the traditional medicine chapter under ICD-11 is a formative step for the integration of such forms of medicine into a classification standard used in conventional medicine. “It also provides the means for doing research and evaluation to establish its efficacy,” he said.

The Ministry added that this chapter would also help to respond to growing demands for more and better regulation of traditional medicine, and its integration in mainstream health care and health information systems.

ICD-11 covers Chinese medicine

After a decade of repeated consultations, ICD-11 had facilitated the inclusion of Module-1, which covers traditional medicine conditions originating in ancient China, which are now commonly used in China, Japan, Korea, and elsewhere around the world.

The eleventh revision contains around 17,000 unique codes and more than 1,20,000 codable terms, which are now entirely digital. ICD-11 came into effect from January 2022.

The joint use of ICD-11’s chapter on traditional medicine along with other chapters on neoplasm, patient safety, and injuries, can enhance the reporting of adverse events. It will enable the integration of traditional medicine into insurance coverage and reimbursement systems, in line with larger WHO objectives relating to universal health coverage. It will also link traditional medicine practices with global conventional medicine’s norms and standard development.

The development of Module-2 for Ayurveda-related diagnostic systems is being actively supported by the Ministry of Ayush. It extensively banks on the implementation experience gained on the ground by the National Ayush Morbidity and Standardised Terminologies Electronic portal, and the Ayush Health Information Management System, the Ministry said.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products

What is the traditional Indian medical system called?

Safety considerations for herbal therapies remain important for clinicians and patients.

Title:

Content: Health & Fitness
Beware of eating unknown herbal recipes for weight loss..
Vulnerable to oxidation and fungus
Thank you for reading the news about beware eating unknown herbal recipes for weight loss..
Exposed to oxidation and fungi Now with the details
Cairo - Samia Sayed - Many people rely on natural products such as: herbal supplements for weight loss or recipes Baladi as some call them, which are sold when Attar, but these recipes have health risks we know in this report.
Dr. Sherry Ansi Najib, Consultant Dietitian, Faculty of Medicine, Ain Shams University, revealed that most herbal supplements contain limited or no data to support the effectiveness of weight loss and not ensure its safety in the long term, herbal products may have the ability to cause harmful interactions between dietary supplements and some prescribed medicines.
As for the composition of herbs sold for Al-Attar, the nutrition consultant explained in a special statement to "Gulf 365", that the herbs sold at Al-Attar may be unsterile, as placing them inside the bags exposed to air are also highly susceptible to the occurrence of oxidation, and are prone to rot and fungus on them, and when taken in the wrong doses may cause problems in the digestive system, most famous diarrhea.
The doctor explained that these formulations cause the loss of the body of sodium and potassium and not only water, and that the frequent intake may cause dehydration in the body, and its natural alternatives explained that the doctor can take natural diuretics, the most important of which is celery, which can be put on the soup causes the loss of excess water, but provides the body with natural vitamins without losing important nutrients from the body.
And the safe herbs can be eaten ginger and cinnamon thrown, but it is preferable to buy the coated type from the pharmacy to avoid exposure to oxidation.
You can follow the news of Egypt and the world from our website
Advertisements

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Establishing rules for the safe, fair, and effective use of traditional medicine

Some Ayurvedic products have been found to contain heavy metals, and rare cases of lead poisoning have been documented, highlighting the need for sourcing from reputable, quality-checked suppliers.

Title:

Content: Skip to main content

2 B.C. lead poisonings likely linked to herbal medicines prompts warning

Herbal medicines are pictured in this image used on HealthlinkBC's webpage about Ayurveda.
Share

Fraser Health issued a health warning Monday after two recent cases of lead poisoning in its jurisdiction.

The health authority, B.C.’s largest by population, said the poisonings are likely associated with Ayurvedic medicines and products that contain opium.

Ayurveda is a traditional medicine system that has been practiced in India for thousands of years.

“Ayurveda emphasizes good health and prevention and treatment of illness through lifestyle practices such as massage, meditation, yoga and dietary changes and the use of herbal remedies,” officials explained in the alert.

Ayurvedic herbal medicines—which include opium products known as doda and afeem that are made from poppy plants—sometimes contain high levels of heavy metals, which can be harmful, according to the health authority.

The herbal medicines may also cause side effects, trigger allergic reactions or interact with other medications, the warning says.

Fraser Health says lead poisonings are rare, but it can be “very difficult to tell” if doda and afeem or other Ayurvedic medicines are contaminated with the heavy metal just by looking.

“If the product has a label, look for a Natural Product Number (NPN) to find out whether the product is registered with Health Canada,” the warning reads. “If you are using a product without an NPN, or using doda or afeem, you can talk to your health care provider about other options.”

Fraser Health says to monitor for symptoms of lead poisoning if you or someone you know are using Ayurvedic products. They include mild symptoms such as fatigue, irritability, headaches, muscle pain, abdominal pain, constipation, vomiting or tremors. Severe symptoms include more serious pain, seizures, reduced consciousness, numbness and weak muscles.

The health authority urges anyone experiencing lead poisoning symptoms to seek medical attention and call the BC Drug and Poison Information Centre at 604-682-5050 or 1-800-567-8911.

CTVNews.ca Top Stories

LIVE RNC UPDATES

LIVE RNC UPDATES JD Vance officially nominated at RNC

The Republican National Convention kicked off this week, with delegates and officials descending on Wisconsin amid the tumult that follows a Saturday assassination attempt on Trump as he becomes the GOP’s official nominee. Follow for live updates of the RNC.

DEVELOPING

DEVELOPING Motive of man who tried to assassinate Donald Trump remains elusive

Former U.S. president Donald Trump called for unity and resilience after an attempt on his life injected fresh uncertainty into an already tumultuous presidential campaign, while President Joe Biden implored Americans to 'cool it down' in the final stretch and 'resolve our differences at the ballot box.'

Stay Connected

Herbal products can interact with conventional medicines—examples include interactions with blood thinners—and adverse effects such as gastrointestinal or cardiovascular symptoms have been reported with some supplements.

Title:

Content: Monday, 25 December 2023 01: 49 GMT
Because of its frequent consumption in winter.. Warning of drug interactions with these herbs
(MENAFN- Al Watan) King Saud Medical City, a member of the first Riyadh Health Gathering, stressed that herbal preparations are closely related to the winter season, as they represent an important part of traditional medicine around the world, because of their benefits, which are used to warm the body and relieve the symptoms of colds and flu, in turn, these preparations can cause side effects at high doses and for long periods, especially people with chronic diseases. Common: stomach disorders, allergies and drug interactions.
The city explained that drug interactions represent the most important and largest part of the side effects, and herbal preparations can interact with drugs, which may lead to reactions and serious side effects, and the possibility that these reactions occur in several ways, including: changing the way the drug works, changing the way the drug is metabolized and increasing the risk of bleeding.
She gave examples of the interactions of herbal preparations with drugs, saying: Ginger, contrary to blood-thinning drugs, and in case of too much of it may lead to bleeding, and licorice can conflict with heart drugs; which may lead to disturbances in the pulse.
She pointed out that licorice also interferes with pressure drugs, which leads to low levels of pressure, as it interferes with a large group of drugs that are metabolized in the liver by some enzymes, and may lead to reduce or increase the effect of the drug such as: some blood thinners, and cholesterol-lowering drugs.
She noted that when excessive use of cinnamon herb, it may lead to disruption of potassium levels in the blood, which may interfere with heart medications and lead to serious side effects.
With regard to grapefruit, she pointed out that it contains active substances known as (furanocoumarins) and cause to reduce the efficiency of most enzymes responsible for the metabolism of most drugs, and reduce or increase their therapeutic effect, and may have a negative and dangerous effect, and can conflict with grapefruit drugs and some pressure Epilepsy and cholesterol-lowering drugs, which increases the effect of the drug, as it interferes with some antibiotics and interferes with anti-diabetic drugs.
She added that chamomile is a conflict with blood-thinning drugs when taken too much, increasing the risk of bleeding, and can interfere with drugs that cause drowsiness to increase its severity, indicating that chamomile may interfere with contraceptive drugs and reduce its effectiveness.
The city stressed the need to include the diet a fixed amount of vitamin K, in terms of vegetables containing it, such as: cabbage, spinach, cabbage, broccoli, chamomile, green tea and others, where it interferes with warfarin, and the sudden increase of it may increase the risk of bleeding.
She explained that the bitter conflict with drugs that lower the level of sugar in the blood, which causes a decrease in the level of blood sugar, and can interfere with warfarin, and reduce the effectiveness of the drug, which causes clots, and the fenugreek is incompatible with sugar drugs, and causes a decrease in the level of blood sugar, and can conflict with blood-liquefaction drugs, and contain a high content of heavy metals. Sugar, which causes a decrease in blood sugar level, and interferes with pressure medications; which may lead to lower pressure levels and can interfere with epilepsy medications and reduce their effectiveness.
She concluded by stressing the importance of consulting the attending physician or pharmacist before taking any herbal preparations, especially if the person has any medical condition or takes medicines, and if you notice any side effects should immediately stop using herbal preparations, as they are an addition to the diet, but it is important to consult a doctor or pharmacist before taking them.
MENAFN25122023000089011017ID1107654823
Legal Disclaimer:
MENA Financial Services Network provides information "as is" without any representations or warranties...
This disclaims our responsibility for the privacy practices or content of the sites included in our network, including images and videos.
For any queries regarding the use and reuse of this source of information, please contact the provider of the above article.
NEWSLETTER
LATEST NEWS

Regulators and public health agencies have also flagged instances of adulteration with banned substances in herbal products, underscoring the need for stricter oversight and consumer vigilance.

Title:

Content: Four drugs sold online contain steroids and banned substances after the public took adverse reactions
Subscriber
Font Size:
Four drugs sold online contained steroids or banned substances, and four members of the public developed adverse reactions after taking them, one of whom was hospitalized.
The Health Sciences Bureau issued a statement on Wednesday (July 12) saying that “ENRU PLUS + ” and“ HKT HERBA KURUS TRADISI ” contain the banned weight-loss drug sibutramine; “PILL HUA LUO CIN TAN ” contains the powerful steroid dexamethasone, Diclofenac and prednisolone;" Spinach GINSENG HERB SUGAR "contains the potent anti-impotence drug Tadalafil.
A man about 50 years old in Malaysia, a so-called "traditional Chinese medicine pharmacy" to buy "Li Shizhen Huo Huo Jin Dan" for a month, the commonly known as "moon face" Cushing's syndrome (Cushing's syndrome), hepatitis also relapsed, for which he was hospitalized for treatment.
Sign up to continue reading the full article!
LIKE Our official Facebook page for more information

The global herbal medicine market was USD 201.06 billion in 2022 and is projected to reach USD 371.45 billion by 2030 at an 8.02% CAGR, with India home to several leading companies and a growing role in pharmaceutical and nutraceutical segments.

Title:

Content: Herbal Medicine Market Size to Reach USD 371.45 Billion by 2030 | Exclusive Report by Fortune Business Insights™

Key Companies in Herbal Medicine Market are Cultivator Natural Products Pvt. Ltd. (India), 21ST Century HealthCare, Inc. (U.S.), Herbalife Nutrition (U.S.), ZeinPharma Germany GmbH (Germany), Blackmores Limited (Australia), Himalaya Global Holdings Ltd. (India), Nutraceutical Corporation (U.S.), Emami Limited (India), Nature's Answer, LLC. (U.S.), Patanjali Ayurved Limited (India), and more players profiled.

Pune INDIA

Pune, India, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global herbal medicine market size was valued at USD 201.06 billion in 2022 and is expected to be worth USD 216.40 billion in 2023. The market is projected to reach USD 371.45 billion by 2030, recording a CAGR of 8.02% during the forecast period.

Herbal medicines are made from natural ingredients to treat a wide range of diseases and improve an individual’s immunity level. Since there has been a drastic change in people’s lifestyle, the incidence of cardiovascular diseases and chronic stress are on the rise. These factors are expected to boost the adoption of herbal medicines as they claim to have no side-effects, unlike the conventional ones.

Get a Free Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/herbal-medicine-market-106320

Leading Players Featured in the Research Report:

Companies leading Herbal Medicine Market are Cultivator Natural Products Pvt. Ltd. (India), 21ST Century HealthCare, Inc. (U.S.), Herbalife Nutrition (U.S.), ZeinPharma Germany GmbH (Germany), Blackmores Limited (Australia), Himalaya Global Holdings Ltd. (India), Nutraceutical Corporation (U.S.), Emami Limited (India), Nature's Answer, LLC. (U.S.), Patanjali Ayurved Limited (India)

Report Scope & Segmentation:

Report Attributes Details
Forecast Period 2023-2030
Forecast CAGR 8.02%
2030 Value Projection USD 371.45 Billion
Herbal Medicine Market Size in 2022 USD 201.06 Billion
Historical Data 2019-2021
No. of Pages 208
Report Coverage Revenue Forecast, Company Profiles, Competitive Landscape, Growth Factors and Latest Trends
Segments Covered
  • By Application
  • By Form
  • By Region
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Herbal Medicine Market Growth Drivers Growing Adoption of Herbal Ingredients in Cosmetic Products to Boost Market Growth

Browse Summary of this Research Report:

https://www.fortunebusinessinsights.com/herbal-medicine-market-106320

COVID-19 Impact:

Growing Health Concerns During Pandemic Boosted Product Demand

The healthcare and pharma industries experienced long and short-term effects of the pandemic as there were several delays in R&D and manufacturing activities to produce effective medicines for the infection. This situation made people more concerned about their health and wellbeing, which boosted the consumption of dietary supplements and immunity boosters that were made from natural ingredients. This accelerated the market’s progress.

Segmentation:

Growing Usage of Herbal Ingredients in Nutraceuticals and Pharma Products to Boost Market Progress

In terms of application, the market is divided into pharmaceutical & nutraceutical, food & beverages, and personal care & beauty products. The pharmaceutical & nutraceutical segment holds the largest herbal medicine market share as herbal ingredients are increasingly used in dietary supplements and medicines to enhance their performance.

Rising Availability of Herbal Medicines in Tablet & Capsule Form to Augment Market Development

Based on form, the market is segmented into powder, liquid & gel, and tablets & capsules. The tablets & capsules segment is expected to capture the leading market share as herbal medicines are produced in the form of tablets and capsules to ease their access to patients.

With respect to region, the market covers North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

Report Coverage:

The research report offers an in-depth analysis of the market and highlights key aspects, such as leading types, companies, and top product forms. It also provides valuable insights into the market segments and trends, while covering key industry developments. Besides the aforementioned factors, the report encompasses many factors that have contributed to the market's growth in recent years.

Ask for Customization:

https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/herbal-medicine-market-106320

Drivers and Restraints:

Growing Adoption of Herbal Ingredients in Cosmetic Products to Boost Market Growth

Exporters of herbal ingredients in the developing countries are viewing the cosmetics industry as a viable medium to help them expand their operations overseas. A growing number of cosmetics manufacturing companies are incorporating natural ingredients to cater to the robust demand for cosmetics that are good for the face, skin, and body. They are replacing synthetic chemicals with herbal ingredients to boost their product’s performance and expand their customer base.

However, stringent guidelines with respect to using herbal ingredients as raw materials may hinder the herbal medicine market growth.

Regional Insights:

Europe Market to Expand Due to Growing Product Usage in Cosmetics Sector

Europe is expected to lead the global herbal medicine market as the region has a vast cosmetics sector. This can present lucrative opportunities for emerging companies that develop and supply herbal ingredient-based products. Many cosmetic companies across the region are witnessing a strong rise in the demand for personal care & beauty products that are made from natural ingredients. This factor will spur the regional market growth.

North America will also grow at a significant pace as customers across the region are becoming more conscious about their health and wellbeing, which has increased the consumption of dietary supplements.

Competitive Landscape:

Key Companies to Use Various Strategies to Boost Their Product Sales

Some of the major companies in the market include ZeinPharma Germany GmbH, Cultivator Natural Products Pvt. Ltd., Blackmores Limited, Herbalife Nutrition, and many others. They are implementing various strategies, such as partnerships and new product launches to increase their product sales and expand their presence in the global market.

Speak to Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/herbal-medicine-market-106320

Major Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Overview on the Parent Market
    • Supply Chain Analysis
    • Industry SWOT Analysis
    • Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
    • Market Analysis and Insights (in Relation with COVID-19)
      • Impact of COVID-19 on the Market
      • Supply Chain Challenges due to the Pandemic
      • Potential Opportunities Due to COVID-19
  • Global Herbal Medicine Market Analysis, Insights and Forecast, 2019-2030
    • Key Findings / Summary
    • Market Size Estimates and Forecast
      • By Form (Value)
        • Powder
        • Liquid & Gel
        • Tablets & Capsules
      • By Application (Value)
        • Pharmaceutical & Nutraceutical
        • Food & Beverages
        • Personal Care & Beauty Products
      • By Region (Value)
        • North America
        • Europe
        • Asia Pacific
        • South America
        • Middle East & Africa
  • North America Herbal Medicine Market Analysis, Insights and Forecast, 2019-2030
    • Key Findings / Summary
    • Market Size Estimates and Forecast
      • By Form (Value)
        • Powder
        • Liquid & Gel
        • Tablets & Capsules
        • Others
      • By Application (Value)
        • Pharmaceutical & Nutraceutical
        • Food & Beverages
        • Personal Care & Beauty Products
      • By Country (Value)
        • U.S.
          • By Application (Value)
            • Pharmaceutical & Nutraceutical
            • Food & Beverages
            • Personal Care & Beauty Products
        • Canada
          • By Application (Value)
            • Pharmaceutical & Nutraceutical
            • Food & Beverages
            • Personal Care & Beauty Products
        • Mexico
          • By Application (Value)
            • Pharmaceutical & Nutraceutical
            • Food & Beverages
            • Personal Care & Beauty Products

To Be Continued…!

Inquire Before Buying:

https://www.fortunebusinessinsights.com/enquiry/queries/herbal-medicine-market-106320

Key Industry Development:

December 2022 – Dabur expanded its Ayurvedic medicines portfolio by introducing Ratnaprash Sugar-Free and Aampachak Kkadha. The former is said to be good for health and provides strength and stamina, whereas the latter strengthens the digestive system and contains herbs, such as shunthi, bhumiamla, harad, pippali, and others.

Read Related Insights:

By 2028, Dietary Supplements Market to Achieve USD 128.64 Billion | Exclusive Research Report by Fortune Business Insights™

Nutraceuticals Market to Hit USD 658.11 Billion by 2028 | With 9.3% of CAGR

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road,

Baner, Pune-411045, Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Fortune Business Insights™

Linkedin |Twitter |Blogs

Attachment

This market momentum reflects rising consumer demand for natural, holistic options and is being met by India’s integrative policy push, research investments, and institution-building across Ayurveda and related systems.

What does traditional Indian medicine generally treat?

What is the traditional Indian medical system called?

Overall, the current evidence suggests Indian herbal medicine can be a useful adjunct to conventional care for specific conditions such as diabetes, anxiety, and supportive cancer care, while larger, well-controlled clinical trials and strong regulation remain essential to fully establish efficacy and safety.

In what areas have the medical uses of traditional Indian medicine been studied?

What does Berberine, a commonly used herbal material in traditional Indian medicine, treat?

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.